Light scattering studies of hemoglobin association by Wang, Yihua
  
 
 
 
Light Scattering Studies of Hemoglobin Association  
 
A Thesis 
Submitted to the Faculty 
of 
Drexel University 
by 
Yihua Wang 
in partial fulfillment of the 
requirements for the degree 
of  
Doctor of Philosophy 
December 2011 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii 
ACKNOWLEDGEMENT 
 
I would like to express my sincerest gratitude to my advisor Dr. Frank Ferrone, who 
always helps me in my time of need, for giving me this research opportunity, for his 
constant guidance, encouragement, understanding and patience, and for shaping my 
professional and scientific skills. His perpetual energy and enthusiasm in research had 
motivated all his students, including me. One simply could not wish for a better mentor. 
My profound thanks to my thesis committee members: Dr. Jian-Min Yuan, Dr. 
Michel Vallières, Dr. Luis Cruz Cruz, and Dr. Patrick Loll for their guidance and 
insightful feedbacks.  
Special thanks to Dr. Robin W. Briehl and Dr. Suzanna Kwong from Albert Einstein 
College of Medicine for providing part of hemoglobin, which are critical for my 
dissertation work. 
This work could not have been done without the generous help from my colleagues 
in the lab, Dr. Alexey Aprelev, who gave me constructive suggestion on the apparatus 
and shared his knowledge and expertise. Dr. Zenghui Liu, who taught me how to use the 
instruments in the lab and built the amplifier of PMT together with me, Dr. Maria Rotter, 
Dr. Mikhail Zakharov, and Donna Yosmanovich. I extend my deep appreciation to them. 
I would like to give my special thanks to Mr. Wolfgang Nadler, Ms. Maryann 
Fitzpatrick and Ms. Lisa Ferrara for their continuous support in building and maintaining 
laboratory equipments. I would also like to thank all physics department faculty and staff 
who have helped me during my study and research. 
 iv 
I would like to express my deepest thanks to my parents, Zhen Wang and Xiaolan 
Zhang, and two elder brothers, Yibin Wang and Yifeng Wang, for their unconditional 
love and support. My heartily thanks to my wife, Chunli Liu, for being an inspiration, for 
sharing my anxieties and pleasures of my PhD journey, for loving and putting up with me, 
and for everything. 
 v 
Table of Contents 
 
LIST OF TABLES ............................................................................................................ vii 
LIST OF FIGURES ......................................................................................................... viii 
ABSTRACT ..................................................................................................................... xiii 
CHAPTER I. INTRODUCTION ........................................................................................ 1 
a) Abnormal Protein Aggregation ........................................................................... 1 
b) Sickle Cell Disease .............................................................................................. 2 
c) Hemoglobin Structure ......................................................................................... 3 
d) Oxy Hemoglobin and Deoxygenated Hemoglobin (R and T Conformation) ..... 6 
e) Oxygen Binding .................................................................................................. 6 
f) Hemoglobin Polymer .......................................................................................... 6 
g) Hemoglobin Fiber and Crystal .......................................................................... 14 
h) Thermodynamic of Hemoglobin Polymerization and Crystallization .............. 15 
i) Kinetics of Sickle Hemoglobin Nucleation ....................................................... 22 
CHAPTER II. Light Scattering From Multiple Components Solution ............................. 30 
a) Static light Scattering ........................................................................................ 30 
b) Light Scattering From Gases ............................................................................. 30 
c) Light Scattering in Macromolecular Solutions (Two Components) ................. 32 
d) Light Scattering in Multi-component Systems ................................................. 34 
e) Light Scattering By Large Particles .................................................................. 36 
f) Dynamic Light Scattering ................................................................................. 37 
CHAPTER III. Materials and Methods ............................................................................ 45 
a) Light Scattering Apparatus Design ................................................................... 45 
b) Kőhler Illumination ........................................................................................... 50 
c) Limitation of Intensity of Laser Determination ................................................ 53 
d) Measurement of Distribution of Scattered Intensity ......................................... 57 
e) Polarization State of Incident Light .................................................................. 60 
f) PMT Gain Calibration ....................................................................................... 62 
g) Hemoglobin Concentration, Sample Quality and Stability Determination ....... 64 
h) Sample Purification and Preparation ................................................................. 67 
CHAPTER IV. Results ..................................................................................................... 71 
CHAPTER V. Liquid-Liquid Demixing ........................................................................... 94 
a) Liquid-liquid Demixing Phase Transition ......................................................... 94 
b) Flory-Huggins Mean Field Theory ................................................................... 96 
c) Light Scattering in Liquid-Liquid Demixing .................................................. 102 
d) Static Light Scattering Data of Hemoglobin Solution Analyzed By Using 
 vi 
LLD Theory .................................................................................................... 104 
CHAPTER VI. Small Aggregates in Hemoglobin Solution ........................................... 111 
a) Light Scattered from Monomers and Dimers .................................................. 111 
b) The Determination of Thermodynamic Equilibrium Association Constant  .. 116 
c) Light Scattered from Monomers and Oligomers ............................................ 128 
Chapter VII. Conclusion ................................................................................................. 137 
a) The Challenges of LLD ................................................................................... 137 
b) Light Scattered from Oligomers ...................................................................... 144 
 
LIST OF REFERENCES ................................................................................................ 150 
APPENDICES ................................................................................................................ 161 
I) Light Scattering of Multiple Components in Solution .................................... 161 
a) Light Scattering in Solution of up to Four Scattering Components ....... 163 
b) Light Scattering in Solution of up to Three Scattering Components ..... 164 
c) Light Scattering in Solution of up to Two Scattering Components ....... 167 
II) The preparation of sickle hemoglobin solution by chromatography .............. 169 
III) Dynamic light scattering in polydisperse solutions ........................................ 180 
 
VITA ............................................................................................................................... 183 
 
 vii 
List of Tables 
 
4.1 Fitting Parameters of Hemoglobin Samples and Intensity of Incident Light ............. 88 
5.1 Values of ΔH and ΔS Parameters Related to LLD ................................................... 107 
6.1 The ΔH and ΔS of hemoglobin derivatives in monomer and dimer model .............. 117 
6.2 The ΔH and ΔS of hemoglobin derivatives in monomer and oligomer model ......... 135 
A.1.1. Shape Parameters Used to Calculate Thermodynamic Properties of Hard 
Particle Fluids ..................................................................................................... 168 
 viii 
List of Figures 
 
1.1 The Structure of Sickle Hemoglobin ............................................................................ 5 
1.2 The Structure of Sickle Hemoglobin Polymer. ............................................................. 9 
1.3 Two Depictions of the Double Strand of Sickle Hemoglobin Molecules Found in the 
Crystal. ........................................................................................................................ 10 
1.4 The Lateral Contact of Sickle Hemoglobin ................................................................ 11 
1.5 The Axial Contact of Hemoglobin .............................................................................. 12 
1.6 Two Phase Model ....................................................................................................... 16 
1.7 The Activity Coefficients of Hemoglobin .................................................................. 20 
1.8 The Solubility of Deoxyhemoglobin S ....................................................................... 21 
1.9 The Double Nucleation Mechanism ........................................................................... 24 
1.10 Free Energy Barriers of Hemoglobin Aggregates .................................................... 27 
1.11 Free Energy Barriers of Homogenous Nucleation .................................................... 29 
2.1 Dynamic Light Scattering Signal and Correlation Function ....................................... 42 
2.2 Log-Linear and Linear-Log Plot of g1(τ) for Pure Monomer and Bimodal Mixture .. 43 
3.1 A Schematic of the Basic Idea of the Setup ................................................................ 47 
3.2 A Schematic of the Apparatus .................................................................................... 48 
3.3 Kőhler Configurations of Apparatus. .......................................................................... 52 
3.4 The Relation between the Extinction Coefficient of Dye and Temperature in the 
Visible Region ............................................................................................................ 55 
3.5 The Relation between the Extinction Coefficient of Dye and Temperature ............... 56 
3.6 Distributions of Intensity of Scattered Light .............................................................. 59 
 ix 
3.7 Changes in Polarization State of Light Coming in or out of Optical Fiber ................ 61 
3.8 The relative gain of PMT as a function of PMT supply voltage ................................ 63 
3.9 The Absorption Spectra of Hemoglobin Samples ...................................................... 66 
4.1 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 7.7g/dl and 8.4g/dl. .............................................................................. 75 
4.2 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 11.2g/dl and 14.7g/dl ........................................................................... 76 
4.3 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 15.7 g/dl and 16.8g/dl .......................................................................... 77 
4.4 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 17.4 g/dl and 17.8g/dl .......................................................................... 78 
4.5 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 19.5 g/dl and 19.7g/dl .......................................................................... 79 
4.6 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 20.2 g/dl and 20.8 g/dl ......................................................................... 80 
4.7 Intensity of scattered light as a function of temperature for deoxygenated HbS at 
concentration 22.7 g/dl and 23.0 g/dl .......................................................................... 81 
4.8 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbS at 
Concentration 23.6 g/dl and 26.9 g/dl ......................................................................... 82 
4.9 Intensity of Scattered Light as a Function of Temperature for HbSCO at 
Concentration 15.9 g/dl and 33.2 g/dl ......................................................................... 83 
4.10 Intensity of Scattered Light as a Function of Temperature for HbACO at 
Concentration 15.7 g/dl and 33.4 g/dl ....................................................................... 84 
 x 
4.11 Intensity of Scattered Light as a Function of Temperature for Deoxygenated Cross-
Linked HbA (deoxygenated XLA) at Concentration 14.1 g/dl and 29.0 g/dl ........... 85 
4.12 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbA at 
Concentration 11.4g/dl and 28.3 g/dl ........................................................................ 86 
4.13 Intensity of Scattered Light as a Function of Temperature for Deoxygenated HbA at 
Concentration 33.3 g/dl ............................................................................................. 87 
4.14 Intensity of Scattered light and Reciprocal of Intensity of Scattered Light as a 
Function of Temperature of HbACO at 33.4g/dl. ..................................................... 89 
4.15 Intensity of Scattered light and Reciprocal of Intensity of Scattered Light as a 
Function of Temperature of Deoxygenated HbA at 33.3g/dl .................................... 90 
4.16 Intensity of Scattered light and Reciprocal of Intensity of Scattered Light as a 
Function of Temperature of HbSCO at 32.2g/dl ....................................................... 91 
4.17 Intensity of Scattered light and Reciprocal of Intensity of Scattered Light as a 
Function of Temperature of Deoxygenated HbS at 16.8 g/dl. .................................. 92 
4.18 Intensity of Scattered light and Reciprocal of Intensity of Scattered Light as a 
Function of Temperature of Deoxygenated Cross-Linked HbA at 14.1 g/dl. ........... 93 
5.1 The Sketch of Homogenous Solution, Demixed State, and Polymer ......................... 95 
5.2 Phase Diagram in Temperature−Concentration Plane .............................................. 101 
5.3 Spinodal Temperatures of HbA ................................................................................ 105 
5.4 Spinodal Temperatures of HbS ................................................................................. 106 
5.5 The Spinodal Curve and Solubility Curve of Deoxygenated HbS ........................... 110 
6.1 The parameter b of fitting curve of scattered intensity of deoxygenated HbS and 
HbSCO .................................................................................................................... 113 
 xi 
6.2 The parameter b of fitting curve of scattered intensity of deoxygenated HbA and 
HbACO .................................................................................................................... 114 
6.3 The parameter b of fitting curve of scattered intensity of deoxygenated cross-linked 
HbA ......................................................................................................................... 115 
6.4 A comparison of the experimentally measured intensity and theoretically predicted 
intensity ................................................................................................................... 121 
6.5 The equilibrium association constants of formation of dimer in HbA and HbSCO 
samples .................................................................................................................... 124 
6.6 The equilibrium association constants of formation of dimer for all of the hemoglobin 
derivatives ............................................................................................................... 126 
6.7 The ΔS of hemoglobin derivatives in the monomer and dimer model ..................... 127 
6.8 The concentration of monomer c1, dimer c2 and initial concentration c0 of 
deoxygenated HbS at 20°C in the monomer and dimer model ............................... 132 
6.9 The concentration of monomer c1, 13-mer c13 and initial concentration c0 of 
deoxygenated HbS at 20°C in the monomer and 13-mer model ............................. 133 
6.10 The RTlnK13 of deoxygenated HbS in monomer and 13-mer model ..................... 134 
6.11 The ΔS per monomer of hemoglobin derivatives in the monomer and oligomer 
model ....................................................................................................................... 136 
7.1 The free energy barrier of LLD and aggregation in the demixed region .................. 139 
7.2 The concentration dependence of the product of polymer growth rate and 
homogeneous nucleation rate of sickle hemoglobin ................................................. 142 
7.3. The sickle hemoglobin polymer growth rate near the demixed region and 
homogenous nucleation rate in the demixed region ................................................. 143 
 xii 
7.4 The concentration of i-mer in hemoglobin polymerization theory.  ......................... 149  
 xiii 
Abstract 
Light Scattering Studies of Hemoglobin Association 
Yihua Wang 
Supervisor: Frank A. Ferrone, Ph.D.  
 
 
 Abnormal protein aggregation has been suggested to be associated with a growing 
number of diseases. A better understanding of the biophysics and biochemistry of protein 
aggregation process will be essential to understanding the role of such aggregates in 
diseases, and critical to preventing or slowing down the aggregation process. The 
intensity of scattered light from protein solutions is dominated by the concentration 
fluctuations of the solution. This intensity will increase while aggregates are forming in 
the solution.  We have used light scattering to probe the initial stages of sickle 
hemoglobin assembly. We employed a novel micro-method for measuring light scattering 
in a rectangular glass capillary tube that is filled with 24 µL of hemoglobin solution. The 
solution was illuminated by a laser coming out of an optical fiber that is sealed into the 
glass tube. The scattered light was collected by a microscope objective at 90° to the 
incident light, and detected via Photomultiplier tube. The temperature is controlled by a 
thermoelectric stage. We studied the scattered intensities of five hemoglobin derivatives 
solution with various concentrations. We found that the intensity of scattered light kept 
relatively constant at low temperatures but increased after the temperature of the solution 
exceeded some particular value. Deoxygenated sickle hemoglobin, which forms polymers 
above solubility, scatters more light than HbSCO (which does not form polymers and 
differs from deoxygenated HbS by quaternary structural differences), HbACO, 
deoxygenated HbA, and deoxygenated cross-linked HbA (which do not form polymers 
and differ from deoxygenated HbS by an amino acid). We interpreted this by using two 
 xiv 
different theories, liquid-liquid demixing and the appearance of oligomers. We found that 
monomer and some large oligomer coexisting in the solution, which implies that there 
might be metastable states in the free energy landscape of hemoglobin aggregation. We 
obtained the enthalpy changes and entropy changes in the formation of oligomers and 
found that the enthalpy changes do not show concentration dependence. The axial contact 
and the lateral contact are found to have different strengths. We found that the data of 
HbSCO shows surprisingly similar behavior to the data of HbA rather than to that of 
deoxygenated HbS, which suggest that there are no lateral contacts between the HbSCO 
monomers. Aggregates concentration is not a diagnostic for polymerization because of 
that although deoxygenated HbS creates more aggregates at the same concentration and 
temperature than other hemoglobin derivatives, all derivatives can create equal 
concentration of aggregates with varied temperature and monomer concentration.  
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Chapter I: INTRODUCTION 
 
Abnormal Protein Aggregation 
 Aggregation is a process that starts from the association of two molecules 
(proteins, or parts of proteins) that have the potential to form larger structures. Abnormal 
protein assembly and aggregation has been suggested to be associated with a growing 
number of diseases. The aggregation of proteins such as α-synuclein, polyglutamine, 
amyloid-β and tau, and prions lead to Parkinson's disease, Huntington's disease, 
Alzheimer's disease, and prion disease respectively (Dauer et al., 2003; Jones et al., 2002; 
Blennow et al., 2006; Prusiner et al., 1991; Aguzzi et al., 2010; Ross et al., 2005).  The 
aggregation of other proteins, such as γ-crystallins and sickle hemoglobin will cause 
cataracts and sickle cell disease, respectively (Aguzzi et al., 2010; Das et al., 2011; 
Dickerson et al., 1983). The aggregation of amylin (or islet amyloid polypeptide) is 
related to type II diabetes (Lorenzo et al., 1994; Hull et al., 2004; Aguzzi et al., 2010). 
These aggregation of pathogenic proteins can occur within the nucleus (such as 
polyglutamine), cytoplasm (for example α-synuclein), intracellular space (such as sickle 
hemoglobin), extracellular space (such as prion), or both intracellular and extracellular 
space (such as tau and amyloid-ß, Aguzzi et al., 2010). Protein aggregation can have 
many causes, such as a mutation in the disease-related protein, or the absence of genetic 
alterations, which is probably trigged by environmental stress or aging (Ross et al., 2005; 
Jones et al., 2010).  
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 A better understanding of the biophysics and biochemistry of protein aggregation 
process will be essential to understanding the role of such aggregates in diseases, and 
critical to preventing or slowing down the aggregation process.   
 Compared to studying aggregation of protein caused neurodegenerative diseases, 
investigating aggregation of sickle hemoglobin has certain advantage because 
characteristics of hemoglobin, such as structure, function, and pathology, are better 
known at present. Because some protein aggregation have similar features, for example, 
amyloid, the cause of Alzheimer's disease, is a fibrillar aggregate composed of amyloid 
fibrils that is thermodynamically stable, structurally organized filamentous protein 
aggregate (Ross et al., 2005), and sickle hemoglobin polymer, the cause of sickle cell 
disease, is also a fibrous structure. The similarity of the fibrous structure in those protein 
aggregations suggests that the mechanism of those protein aggregations may be also 
similar. Not only can understanding the mechanism of sickle hemoglobin aggregation be 
crucial to preventing or slowing down the aggregation process of sickle hemoglobin 
itself, but it can also help better understanding mechanism of other proteins aggregation. 
 
Sickle Cell Disease 
 Sickle cell anemia is a genetic hemoglobin disease caused by mutation of 
hemoglobin. Hemoglobin, which takes up 95% of the volume of red blood cell (RBC), 
serves to transport oxygen from the lungs to the tissues. The average concentration of 
hemoglobin molecules in blood is ~15g/dl, and the average concentration for hemoglobin 
molecules in the RBCs is ~34g/dl.  While delivering oxygen in the tissues, RBCs need to 
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deform themselves in order to pass through microcirculation capillaries, whose diameter 
is smaller than the size of RBCs. Because normal RBCs are flexible biconcave disks 
without a cell nucleus and most organelles, normal RBCs can deform and restore easily. 
However, RBCs of people who have sickle-cell anemia will be in an abnormal, rigid, 
sickle shape at low oxygen concentration. Those deformed RBCs become more rigid than 
normal erythrocytes, and they are easily to be trapped in the capillaries, at which oxygen 
pressure is only as low as 40 mm Hg, causing inflammation, pain and possible tissue 
death. Although most sickled RBCs can restore their normal shape after binding with 
oxygen again, deformation of a certain number of them will be permanent because of 
their membrane damage. These defective cells have a shorter lifetime than average RBCs 
have, which places a heavy load on the patient’s erythrocyte-generating machinery of the 
bone marrow. The RBCs of a person with sickle cell anemia behaves almost normally at 
the 100-mm Hg oxygen pressure at the lung. 
 There is another form of sickle cell disease called “sickle cell trait”, in which 
RBCs usually contain ~60% normal hemoglobin and 40% sickle hemoglobin. The patient 
who has sickle cell trait usually shows no symptoms. The difference between the cause of 
sickle cell anemia and the cause of sickle cell trait is that it is homozygosity for the 
mutation that cause the former and  heterozygosity for the mutation that cause the latter. 
Heterozygous people have only one sickle gene and one normal hemoglobin gene 
(Dickerson et al., 1983; Noguchi et al., 1985; Natarajan et al., 2011).  
 
Hemoglobin Structure 
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 The hemoglobin molecule is a tetramer consisting of two identical dimers. Each 
dimer consists of one α and one β chains. Each chain is folded in about eight helical 
stretches, linked by short non-helical segments. Those eight helices are denoted A to H, 
around a heme moiety. The structure of hemoglobin molecule is shown in Figure 1.1. The 
α and β subscripts only identify relative positions in the molecule and have no chemical 
significance.  Each α chain (141 amino acids) has a molecular weight of 15126 Daltons. 
Each β chain (146 amino acids) has a molecular weight of 15867 Daltons. Each of the 
four subunits of hemoglobin noncovalently binds a single heme group, which is 
responsible for the characteristic red color of blood. Each heme group consists of an iron 
atom contained in the center of porphyrin, functioning as binding site of ligand such as 
oxygen, or carbon monoxide. The heme adds another 616 Daltons to each chain. The 
hemoglobin tetramer is a spheroidal molecule with dimensions of 65×55×50Å, and the 
weight of 64450 Daltons. In solution, hemoglobin tetramer readily dissociates into two 
dimers and is able to be recombined from any two dimers.  
 The sequence difference between normal hemoglobin (HbA) and sickle 
hemoglobin (HbS) is that the residue at β6 in HbA is Glutamic acid, a polar amino acid, 
rather than Valine, which is hydrophobic, in HbS.  
 There is little contact between α and α, β and β subunits. There are two types of α-
β contacts, which are packing contacts and sliding contacts. The α1β1 or α2β2 contacts are 
named packing contacts because those subunit packing is unchanged when hemoglobin 
molecules goes from its deoxygenated conformation to its oxygenated conformation 
(Subscripts in α and β represent their relative position in hemoglobin molecule). B, G and  
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Figure 1.1. The structure of sickle hemoglobin. Two β subunits are represented in yellow 
and cyan, and two α subunits are showed in green and blue. The positions of mutants are 
showed in red. The four heme groups are shown in ball and stick. The HbS structure is 
PDB ID: 2HBS (Harrington et al., 1997; www.pdb.org).  The Figure was created using 
Jmol (www.Jmol.org).  
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H helices and the GH corner are involved in those contacts. The other type of contacts 
(α1β2 and α2β1) are called sliding contacts, which involves mainly helices C, G and FG 
corner, and they undergo the principal changes when there is ligation state change. Not 
all of the contacts are hydrophobic, and some hydrogen bonds and several salt bridges are 
also involved. The α1β1 interface involves 35 residues while the α2β2 interface contains 
19 residues. The complete hemoglobin molecule has nearly 222 symmetry, with three 
mutually perpendicular twofold axes intersecting at the center of the molecule. Since 
subunits α1 and β1 are not identical in hemoglobin, two of those three axes are 
pseudosymmetry (Dickerson et al., 1983; Voet et al., 1995).  
 
Oxy Hemoglobin and Deoxygenated Hemoglobin (R and T Conformation) 
 Hemoglobin can be called oxy hemoglobin (HbO2), carbon monoxide hemoglobin 
(HbCO) or nitrogen monoxide hemoglobin (HbNO) if it binds with O2, CO, or NO, 
respectively.  Correspondingly, deoxygenated hemoglobin is the form of hemoglobin 
without the bound ligand. The iron atom in heme group normally remains in the ferrous 
oxidation state (Fe2+) whether or not the heme is oxygenated. Once the iron atom in the 
heme group is oxidized to ferric state (Fe3+), the form of hemoglobin is called met 
hemoglobin (metHb). The hemes in metHb will normally bind with a water molecule 
rather than O2 or CO.  
 Oxygenation causes quaternary structural changes to hemoglobin. The most 
distinct difference between deoxygenated and oxy hemoglobin is that the subunits move 
relative to one another when a ligand binds to the hemes. Each α1β1 and α2β2 half of the 
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molecule moves as a rigid body and the two halves slide over one another. In oxy 
hemoglobin, the α1β1 rotates 15° relative to α2β2 about a pivot passing through two α 
subunits. After the rotation, the two α subunits move very little relative to another, but the 
carboxyl ends of the H helices of the β subunits come 7Å closer together in 
oxyhemoglobin than in deoxyhemoglobin. The quaternary conformations of oxy 
Hemoglobin is independent of the ligand (like O2, CO, and NO). The quaternary 
conformation of deoxygenated hemoglobin is named the T state and the quaternary 
conformation of oxy Hemoglobin is called the R state.  
 
Oxygen Binding 
 In blood, 15g/dl hemoglobin are capable of binding 20ml of gaseous O2 if the 
hemoglobin is fully saturated. The actual degree of saturation varies with oxygen partial 
pressure, but the saturation of hemoglobin is almost complete when it passes through the 
lungs. Certain small molecules, such as CO, NO, and H2S have greater affinity to 
hemoglobin than does O2. 
 
Hemoglobin Polymer 
 Intracellular hemoglobin concentrations range from 25g/dl to as high as 50g/dl 
(Seakins et al., 1973; Fabry et al., 1984). At high enough concentration and temperature, 
deoxygenated sickle hemoglobin (deoxyhemoglobin S) molecules will aggregate in a 
specific manner to form long fibers, and then these fibers group themselves into bundles 
of columns that stiffen the cell and push it into an elongated sickle shape. A single 
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hemoglobin fiber has diameter 220Å in average. As shown in Figure 1.2, it is composed 
of seven pairs of zigzag double strands (Wishner et al., 1975; Dykes et al., 1979; 
Edelstein et al., 1981; Padlan and Love, 1985). The fiber has an oval or elliptical cross 
section which combined with a twist in the fiber axis. Crystal structure of double strand is 
shown in Figure 1.3. 
 There are two major intermolecular contacts in sickle hemoglobin fibers, lateral 
and axial contacts. The lateral contact is a contact between hemoglobin molecule in one 
of a double strand and the other molecule from the other strand of the same double strand. 
The major residues involved in later contact include residues Lys 66, Gly 69, Ala 70, Asp 
73, Asp 79, Gly 83, Phe 85, Thr 87 and Leu 88 in one β subunit of former molecule and 
Val 6 in one β subunit from latter molecule.  The lateral contact is shown in Figure 1.4. 
The lateral contact is essential for hemoglobin fiber formation. (Wishner et al., 1975; 
Padlan et al., 1985a, b; Harrington et al., 1997; Dickerson et al., 1983).   
 Contact along the fiber direction is termed an axial contact, which is not only 
mainly formed between β subunit of one hemoglobin molecule and β subunit of another 
hemoglobin molecule, but also formed between α subunit of one hemoglobin molecule 
and β subunit of another hemoglobin molecule. Axial contacts mainly include residues 
Gly 16, Lys 17, Val 18, Glu 22, Pro 114, ALA 115, Phe 118, Gly 119, and Glu 121 of 
one β subunit of one molecule; Pro 114, Ala 115 , His 20 from one α subunit, and Phe 
118, His 117,  His 116 from one β subunit of another molecule (Wishner et al., 1975; 
Padlan et al., 1985a, b; Harrington et al., 1997). The axial contact is shown in Figure 1.5. 
 Within a double strand, the axial contacts in strand 1 are similar but not identical  
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Figure 1.2. The structure of sickle hemoglobin polymer. The polymer fiber consists of 
seven pair of double strands. Each small sphere represents a hemoglobin molecule. 
Molecules that belong to the same double strand are showed in the same color (Mirchev 
and Ferrone, 1997). 
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Figure 1.3. Two depictions of the double strand of sickle hemoglobin molecules found in 
the crystal. (a) The strand is shown as a transparent solvent accessible surface, with the 
mutant Val residue colored red.  (b) The protein backbones are shown as colored coils, 
heme group shown as ball and stick, and mutant Val residues shown as CPK spacefill. 
The HbS structure PDB ID: 2HBS (Harrington et al., 1997; www.pdb.org).  The Figure 
was created using Jmol (www.Jmol.org).  
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Figure 1.4. The lateral contact of sickle hemoglobin. The CPK spacefill models depict 
atoms of acceptor pocket, and bonds decorate Val 6 and Pro 5 of donor, ball and stick 
represent His 50 of donor. The atoms of the acceptor pocket are depicted with carbon 
atoms gray, oxygen atoms red, and nitrogen atoms blue. The atoms of the some residues 
of the acceptor pocket are designated as, Asp 73 orange, Ala 70 green, Leu 88 yellow, 
Heme cyan, Phe 85 black, Thr 84 violet and Asp 79 indigo. The atoms of Val 6 are 
depicted in red, and the atoms of His 50 are in green. The HbS structure PDB ID: 2HBS 
(Harrington et al., 1997; www.pdb.org).  The Figure was created using Jmol 
(www.Jmol.org).  
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Figure 1.5. The axial contact of hemoglobin. The CPK spacefill model depicts atoms of 
the α2 and β2 subunits, and bonds delineate residues in the β1 and α1 loops. The atoms of 
some residues in the α2 subunit are depicted as Ala 115 green, Pro 114 yellow and His 20 
cyan. The HbS structure PDB ID: 2HBS (Harrington et al., 1997; www.pdb.org).  The 
Figure was generated using Jmol (www.Jmol.org).  
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to those in strand 2, and the lateral contacts between Val 6 in strand 1 and the acceptor 
pocket in strand 2 are also similar but not identical to those between the strand 2 Val 6 
and the strand 1 acceptor pocket.  
 There are 574 amino acids in one hemoglobin molecule, but the only sequence 
difference between HbA and HbS is one amino acid (Val) in each β6. Why can Val make 
hemoglobin polymerize?  
 In order to answer this question, we need to know the lateral contact and axial 
contact in detail. There is a hydrophobic pocket at the EF corner of each β subunit in a 
hemoglobin molecule. To form lateral contact, the donor, the mutant Val 6 at one β 
subunit from one molecule needs to fit into the acceptor, the hydrophobic pocket of the 
other molecule. Since each hemoglobin molecule consists of 2α and 2β subunits, 
individual subunits are designated in the following notation (Padlan and love, 1985a, b). 
β units acting as acceptor pocket for mutant Val are named β1 and β units acting as Val 
donors are termed β2. The α subunits are designated according to their positions relative 
to the β subunits. Subunits within molecule 1 or 2 are preceded by 1 or 2, respectively.  
The acceptor pocket is lined at the bottom with the side chains of 1β1Leu 88 and 1β1Phe 
85, and has 1β1 Asp 73, 1β1Thr 84, and 1β1Thr 87 around the perimeter. The donor 
begins at 2β2Thr4 and 2β2 Pro 5, and critical 2β2Val 6 site is located in the first helical 
turn, followed by 2β2Ser 9 (Wishner et al., 1975; Padlan et al., 1985a, b; Harrington et al., 
1997; Dickerson et al., 1983). In this region, there is also a salt bridge between 2α2 His50 
and 1β1 Asp79. This contact is possible reason for the pH dependence of the polymer 
solubility (Ferrone 2004). 
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 Because charge residues have no attraction for this hydrophobic pocket, lateral 
contacts cannot occur between HbA molecules, which have charge residue Glu on the β6 
position. This is the exact reason for which HbA cannot polymerize because sickling 
behavior requires both lateral contact and axial contact existing on the same hemoglobin 
molecule.  
 Upon oxygenation, 1β1Phe 85 is pulled toward the center of molecule, away from 
the potential contact 2β2Val 6. Because of that structure shift, although oxy sickle 
hemoglobin molecule can have lateral contact, it cannot have both lateral contact and 
axial contact at the same time. 
  Upon deoxygenation, 1β1Phe 85 is moved back and the hydrophobic pocket is 
restored. The hydrophobic donor 2β2 Val 6 can nest closely into the hydrophobic pocket. 
The acceptor pocket buries the 2β2 Val 6 in the lateral contact, removing it from solvent 
interaction. Only in the deoxyhemoglobin conformation, is the acceptor pocket shaped in 
a way that supports interaction with hydrophobic side chains from the donor, and only in 
this state does fiber grow. 
 
Hemoglobin Fibers and Crystal 
 When highly purified sickle hemoglobin solutions are stirred for several hours, 
thin fibers first develop and collect into bundles or fascicles, and then these fascicles 
anneal to form crystalline needles. It suggests that there must be very close connection 
between sickle hemoglobin crystal structure and fiber structure (Wellems et al., 1979, 
1980, 1981). 
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 Contacts between molecules within a zigzag double strand in hemoglobin fibers 
are similar to those in the crystal, but the contacts between different double strands in 
fibers could be quite different from those in crystal. The double strands in the crystal are 
packed linearly, whereas the double strands in the fibers are twisted into a right-handed 
helix (Dickerson et al., 1983).  
 
Thermodynamic of Hemoglobin Polymerization and Crystallization 
 Thermodynamically, sickle hemoglobin polymerization can be well described in a 
two phase model, from gas to solid, as shown in Figure 1.6. Because of a lack of long 
range interaction between molecules, hemoglobin monomers in solution can be treated as 
a gas. The polymer phase has the properties of a solid because of its ordered structure. 
Those two phases are in equilibrium in the process of polymerization. The concentration 
of the polymer phase is close to the concentration of hemoglobin crystal, and the 
concentration of the solution phase is determined by the solubility of deoxygenated sickle 
hemoglobin.  
 The solubility of deoxyhemoglobin S, which is usually represented by Cs or Csat, 
depends on temperature, and pH value of solution (Ross et al., 1977; Adachi et al., 1978). 
The solubility of deoxyhemoglobin S as a function of temperature is shown in Figure 1.7. 
Near physiological condition, solubility of deoxyhemoglobin S is 16.3g/dl at 37°C pH 
7.15 (Ross et al., 1977). Adding crowding agents usually lower the solubility (Himanen 
et al., 1996; Bookchin et al., 1999; Liu et al., 2008).  
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Figure 1.6. Two phase model. (a) Monomer in solution phase. (b) Polymer phase. 
Monomers and polymers will be in thermodynamic equilibrium when the concentration 
of the solution reaches solubility. 
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 The solubility of deoxyhemoglobin S is usually determined by using a 
sedimentation method, in which the concentration of hemoglobin in the supernatant is 
measured as solubility. This value is independent of initial hemoglobin concentration 
(Hofrichter et al., 1976). The solubility of deoxyhemoglobin S crystals is about 30% less 
than that of deoxyhemoglobin S polymers (Jones et al., 1979). 
 When the chemical potential of molecules in the solution and that of polymer 
phase are equal to each other, the solution reaches thermodynamic equilibrium 
(Hofrichter et al., 1974). If the chemical potential of molecules in solution phase is 
designated µm, it can be expressed as (Ross et al., 1977; Ferrone et al., 1985).  
cRTSRSTm γµµµ ln++=                                                        (1.1) 
here, µST represents translational entropy , µSR denotes rotational entropy, c is 
concentration of monomers, R is the gas constant, and T is the absolute temperature. γ is 
called the activity coefficient, which is due to the nonideality of molecular crowding. In a 
red blood cell, hemoglobin is in a very crowded environment. For example, at 34g/dl, the 
distance between centers of two adjacent hemoglobin molecules is only 1.6 molecular 
diameters, which means that two molecules are only 0.6 molecular diameters apart edge 
to edge. Because of that, the molecular interactions have to be scaled by activity 
coefficients, γ (Minton 1981, 1983). Activity coefficients are extremely dependent on 
concentration. For example, if hemoglobin molecule is viewed as hard sphere, γ=171.7 at 
c=40g/dl, while γ=5.6 at c=20g/dl. Over the range of concentration observed for 
hemoglobin, there is a simple and accurate expression for γ (Ferrone and Rotter, 2004). 
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where φ is the volume fraction and can be calculated as:  
φ=Vc                                                                 (1.3) 
here, V is specific volume of a hemoglobin molecule, and V=0.77cm3/g for hemoglobin. 
The activity coefficient of hemoglobin is shown in Figure 1.8.  
 The translational and rotational energy describe the motional freedom a monomer 
can have and quantitatively represent the entropy that they must give up in aggregation. 
These two terms can be described in following equations (Hill 1986).  
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Here, m is the mass of the molecule, k is Boltzman’s constant, h is Planck’s constant, NA 
is Avodagro’s constant, I is moment of inertia of the molecule, V0 is the reference 
volume and σS is a symmetry number.  For hemoglobin, NA/V0 is 6.023×1020 molecules 
per liter if we use 1mM reference state, for which c has to be in unit mM in equation 1.1.  
 The chemical potential of hemoglobin in polymer phase µP  is given by: 
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                                                      (1.6) 
µPV represents internal vibration, which comes from vibration ability of hemoglobin 
monomer around equilibrium position in polymer.  It can be described as the result of 
normal modes of vibration of a polymer. In the Einstein modle of a solid where there is 
only one frequency, 
)ln(6
E
PV h
kTRT
ν
µ −=
                                                  (1.7) 
where νE is the Einstein frequency. µPC stands for contact energy, which includes all the 
interactions that constitute both lateral and axial contacts among hemoglobin molecules 
in polymer. 
 
 At thermodynamic equilibrium, the chemical potential of the molecules in 
solution phase equals to that of in polymer phase.  
                                                                                 (1.8) 
which gives a simple equation for solubility, 
RTc SRSTPVPCSS /)(ln µµµµγ −−+=                                       (1.9)  
If µPC is known, solubility can be calculated directly.  
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Figure 1.7. The activity coefficients of hemoglobin. The curve is calculated by using 
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= (Ferrone and Rotter, 2004). Hemoglobin molecule is viewed as hard 
sphere. 
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Figure 1.8. The solubility of deoxyhemoglobin S as a function of temperature in 0.15 M 
potassium phosphate, 0.05 M-sodium dithionite, pH 7.15. The solid circles represent 
experimental data (Ross et al., 1977), and the line shows a fitting curve.  
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Kinetics of Sickle Hemoglobin Nucleation 
 Kinetic studies have played a central role in understanding the pathophysiology of 
sickle cell disease and the physical chemistry of sickle hemoglobin polymerization. Both 
in the red cell and within the solution, the polymerization of HbS follows an unusual 
autocatalytic time course. A solution of HbS can reach the condition under which it will 
grow polymer by lowering the pressure of oxygen, raising the temperature of the solution, 
and/or raising the HbS concentration. Once the gelation condition is reached, there is a 
delay that varies according to conditions from milliseconds to days. During this delay 
period, no HbS fibers are detected (Hofrichter et al., 1974a, b; Malfa and Steinhardt, 
1974; Moffat and Gibson, 1974). The delay time is extraordinarily sensitive to the 
temperature and initial HbS concentration (Hofrichter et al., 1974a), to the fractional 
saturation with oxygen (Gill et al.,1980) or carbon monoxide (Hofrichter et al., 1976a; 
Eaton and Hofrichter 1978), to the presence of other hemoglobin (Sunshine et al., 1978, 
1979b). After the delay, there is an explosive, autocatalytic formation of polymer 
(Hofrichter et al., 1974a, b; Malfa and Steinhardt, 1974; Moffat and Gibson, 1974). In 
particular, the tenth time depends inversely on the initial HbS monomer concentration to 
a very high power. In the range 20 to 30g/dl, the tenth time varies as the 36th power of the 
HbS concentration (Hofrichter et al., 1974b, 1976b; Sunshine et al., 1979b), while in the 
range 30 to 40 g/dl, the tenth time decreases to16th power of the HbS concentration 
(Ferrone et al., 1980, 1985a). The delay time has been defined as the intersection of the 
maximum slope of the progress curve with the time axis and the tenth time is defined as 
the time required reaching 10% of the maximum signal amplitude.  A striking feature of 
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the kinetics of hemoglobin polymerization is that, while the kinetics of hemoglobin 
polymerization progress curves are highly reproducible if delay time is less than about 
ten seconds. The delay time shows stochastic behavior on small sample volumes(10-10 to 
10-9 cm3) when the average delay time is longer(Ferrone et al., 1980, 1985a,b;  Hofrichter, 
1986). 
 These findings have been well explained by the nucleation mechanism called the 
double nucleation mechanism. The mechanism postulates that there are two pathways for 
the nucleation of polymers: homogeneous and heterogeneous nucleation (Ferrone et al., 
1980, 1985b). In a solution devoid of polymers, aggregates are created randomly. These 
aggregates are unstable and likely to dissolve rather than to grow. Finally, the random 
dynamics of the solution will produce an aggregate that crosses the stability barrier. This 
most unstable aggregate is named as the critical nucleus. The size of this critical nucleus 
depends on temperature and concentration of solution. Because adding a monomer to this 
critical nucleus increases stability rather than diminishes it, a full-fledged polymer is 
eventually created. This process is called homogeneous nucleation. Once any polymer is 
formed in the solution, it allows another type of nucleation to occur. This second pathway 
is called heterogeneous nucleation, in which the lateral surface of the polymer may serve 
as a template for the nucleation of new polymers. Since the first polymer has been formed, 
both homogeneous and heterogeneous nucleation will contribute to the polymerization.  
 The extra stabilizing interactions between the aggregate and the polymer’s surface 
make heterogeneous nucleation be more feasible than homogeneous nucleation. Because 
the available polymer surface is continuously increasing with time during polymerization,  
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Figure 1.9.  The double nucleation mechanism. Polymer may form through two pathways. 
The first one is a homogeneous nucleation, through which polymer forms by the 
formation of an aggregate called critical nucleus. The formation of critical nucleus is 
energy unfavorable. Once polymers are formed, new polymer can grow on the surface of 
the existing ones. This is called heterogeneous nucleation. As shown by the reaction 
arrows, aggregation is favorable once past critical nucleus in either pathway. 
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the rate of heterogeneous nucleation also increases continuously.  
 The formation of both homogeneous and heterogeneous nuclei is driven by 
hydrophobic forces. The chemical potential of an aggregate containing i monomers is 
given by: 
iiiViCiRiTi cRT γµµµµµ ln++++=                                            (1.10) 
Here, ci is the concentration of an aggregate containing i monomers, γi is the activity 
coefficient of the i-mer. µiC stands for contact energy, and µiV represents internal 
vibration energy. µiT is the translational energy of aggregate,   
 STiT iRT µµ +−= ln2
3
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µiR is rotational energy of aggregate,                          
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ρ is ratio of aggregate density to monomer density. We can use ratio of polymer density 
(0.69g/cm3, Sunshine et al., 1979) to monomer density (1.26g/ cm3) as the value of ρ, 
which is 0.55. σi is  symmetry number of the aggregate, and I(i) is moment of inertia of 
the aggregate. If we assume that aggregate is a sphere, we have: 
                                       (1.12) 
here, I is the moment of inertia of the monomer, mi is mass of the aggregate, and Ri is 
radius of the aggregate. The contact energy of the aggregate with size i is given by: 
         CiC ii µδµ )(=                                                          (1.13) 
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where, δ(i) stands for the fraction of contacts present in an aggregate with size i, relative 
to an infinitely large aggregate(Ginnel 1961).  δ(i) has an empirical expression; 
                                 iiii //)ln(1)( 21 δδδ −−=                                             (1.14) 
here δ1=1.29±0.04, δ2=0.84±0.08 (Ferrone et al, 1980,1985 b). µC represents the contact 
energy of aggregate, which is usually replaced by µPC, the average value of contact 
energy for polymer. The vibrational potential of the aggregate, µiV, is given by: 
  PViV i µµ )1( −=                                                            (1.15) 
 At equilibrium, the chemical potential of aggregate of size i will equal to that of 
its i constituents, 
            mi iµµ =                                                                     (1.16) 
Substituting equations 1.1, 1.9-1.15 into equation 1.16 gives the activity of aggregate of 
size i (Ferrone et al, 1985 b): 
ssPCPC
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ii cRTRTRTiRTc
ciRTcRT γµδρµδ
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      (1.17) 
The above equation gives the total free enery change for the formation of aggregate, 
which is shown in Figure 1.10. Because the critical homogeneous nucleus should be the i-
mer that has the minimum value of the activity, the size of critical homogeneous nucleus 
i∗, can be obtained by differentiating the right side of equation 1.17 with respect to i and 
equating to zero. It gives (Ferrone et al, 1985 b): 
   S
RTi PC
ln
/4 1µδ+−=∗                                                      (1.18) 
here S is the supersaturation, defined as γc/γscs. Eqn 1.18 shows that the critical  
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Figure 1.10. Free energy barriers of hemoglobin aggregates. The total free energy change 
for the formation of an aggregate if size i ,-RTlnγici (eqn 1.17), is plotted as a function of 
aggregate size for a series of concentrations in steps of 0.5mM spanning from 
3.0mM(highest curve) to 6.0mM(lowest curve). The parameters used to generate the 
curve are as follows.  T= 25 °C, µPC = -7.5kcal/mol (Cao and Ferrone 1997), and Cs is 
0.176g/cm3 (Ross et al. 1977). 
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homogenous nucleus size depends on the supersaturation, which in turn depends on 
initial concentration at certain temperature.  
 In eqn 1.13, in order to get the expression of the total contact energy of the 
aggregate with size i, µPC, the average contact energy for polymer is used to substitute the 
energy per contact.  Because the polymer has both lateral and axial contacts, using this 
average value as substitution of contact energy for aggregate actually assume that lateral 
contact and axial contact have same energy. What if interaction of lateral contact is 
actually different with that of axial contact? Is this assumption still accurate enough to be 
used in formation of small aggregates, such as dimer, which only has either lateral or 
axial contact, or trimer, which has uneven number of lateral and axial contacts? 
  Obviously, changing µPC will affect the free energy barrier in the formation of 
aggregate, as shown in Figure 1.11. If the contact energy of the dimer and trimer is 
different than what eqn 1.13 describes, is it possible that the free energy barrier of 
nucleation has some local minima, as also shown in Figure 1.11. Is there a way to help us 
answer this question?  
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Figure 1.11. Free energy barriers of homogenous nucleation. (a) Free energy barriers for 
homogenous nucleus formation as a function of aggregate size for initial concentration of 
solution 4mM with a series of µC in step of -1kcal/mol spanning from -7.5 kcal/mol 
(highest curve) to -2.5kcal/mol (lowest curve). The free energy of monomers have been 
set to a common zero. (b) Free energy barrier for homogenous nucleus formation as a 
function of aggregate size for initial concentration of solution 4mM with µC -7.5 kcal/mol 
(black) and possible free energy barrier for homogenous nucleus formation if trimer is 
more stable than dimer (red). 
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Chapter II: Light Scattering From Multiple Components Solution 
 
 Light scattering methods have been well utilized to characterize certain properties 
of macromolecules in solution. Static light scattering (SLS) methods can be used to 
obtain the average molecular weight of molecules and the second virial coefficient, which 
is a useful index of solute solvent interactions. Dynamic light scattering (DLS) methods 
can yield information on the distribution of diffusion coefficient of molecules, and 
subsequently, the size distribution of molecules. In some case, the methods may also 
illuminate the possible shape of large macromolecules.  
 
Static Light Scattering 
 In static light scattering (or classical light scattering), the intensity of light is 
measured by averaging the fluctuating intensity of the scattered light at a certain 
scattering angle.   
 
Light Scattering From Gases 
 The Rayleigh ratio of scattered intensity to unpolarized incident light intensity for 
gases is: 
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Here, I0 stands for intensity of incident light, IS is intensity of scattered light from per unit 
volume of the scattering gases, θ is the angle between incident light and the direction of 
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observation, r is the distance between center of scattering gases and observer, λ is 
wavelength of incident light, Nk is number of scattering molecules of gases, α is the 
molecular polarizability, which is isotropic in this equation.  If incident light is polarized, 
φ
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φ 24
24
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sin16)( kS NI
rIR ==
                                                    (2.2)                            
Here φ represents the angle between the axis of oscillating dipole and the direction of 
observation.  The oscillating dipole is induced by the incident light in any molecule in its 
path.  
 Three limitations have been used to get eqn. 2.1 and 2.2. The first restriction is the 
assumption that the scattered light has the same frequency as the incident light. The 
second limitation is that the scattered light from particles is independent of each other, 
which means no interference. In order to ensure this independent scattering, the distance 
between particles should be at least 3 times larger than the radius of particle, or even 
larger. In solution, the distance between two adjacent hemoglobin molecules are much 
less than 3 times of the radius of hemoglobin molecule. For example, the distance 
between the centers of two adjacent hemoglobin molecules is only 1.6 molecular 
diameters when concentration of hemoglobin is 34g/dl. The third one is that multiple 
scattering is also neglected (van de Hulst 1981). In most cases, information about the 
refractive index is known. Since the polarizability is related to the refractive index n, we 
get 
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                     απNn 412 =−                                                                    (2.3) 
where, N is the number of molecules per unit volume.  
 
Light Scattering in Macromolecular Solutions (Two Components) 
 The Rayleigh theory of light scattering in gases cannot be used in liquids because 
intermolecular forces in liquids are much stronger than those of in gases. The Rayleigh 
ratio for pure liquids in a certain volume cannot be the product of the number of liquid 
molecules in that volume and Rayleigh ratio for a single liquid molecule anymore.  
 In pure liquids, scattering is considered to be caused by density fluctuation at 
local pressure and temperature because at any instant the number of liquid molecules in 
one volume element always differs from that of in another volume element due to random 
thermal motion of the molecules. This causes the fluctuation of the polarizability 
(Einstein 1910, Smoluchowski 1908). In macromolecular solutions, scattering results 
from both density fluctuation of solvent and concentration of macromolecular fluctuation 
(Debye 1944). The Rayleigh ratio for macromolecule solution with solvent and one 
species of solute is given by: 
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here, Δα is the polarizability fluctuation due to density and concentration fluctuation, and 
〈(Δα)2〉 is time average of (Δα)2. We have, 
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where, T represents the absolute temperature, P is pressure, and c is the concentration of 
macromolecules in the solution, in unit mass per unit volume. The first two terms on the 
right side of eqn. 2.5 are ignored because they are assumed to be the same as the 
corresponding terms for scattering of the pure solvent. What we are actually interested in 
light scattering in solution is commonly known as the excess Rayleigh ratio, which is the 
difference between the Rayleigh ratio of the solution and the pure solvent: 
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here, Δc is the concentration fluctuation and 〈(Δc)2〉 is the average of (Δc)2, and NA is 
Avogadro’s number. Iʹ′S represents the difference between intensity of scattered light from 
solution and the one from pure solvent. It is Rʹ′(θ) that is usually measured in light 
scattering from macromolecule solutions experiments.
  
 In order to simplify the description, from now on, only equations for unpolarized 
incident light will be discussed. The difference between Rayleigh ratio of scattered 
intensity to polarized incident light and the one to unpolarized incident light is the factor 
2sin2φ in place of (1+cos2θ). 
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 Since  〈(Δc)2〉 can be expressed in terms of derivative of chemical potential of 
solution with respect to concentration of solution, we have, 
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here, V1 is partial molal volume of solvent and µ1 is the chemical potential of solvent.  
 If the analytical expression of chemical potential in terms of concentration is 
unknown, the change of the chemical potential with the concentration can be described as 
the change of the osmotic pressure with concentration: 
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here Π stands for osmotic pressure, 
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where A2, A3 are virial coefficients of the osmotic pressure, and M is the molecule weight 
of solute, so that eqn. 2.8 becomes 
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Light Scattering in Multi-component Systems 
 For solution with more than two components, the Rayleigh ratio cannot be 
obtained by using the above equations, unless the refractive index of solvent mixture is 
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independent of its composition (Tanford 1961). The intensity of light scattered from 
small particles (<20nm) exhibits a minor angular variation. On the condition that the 
angular dissymmetry of the scattered light is negligible, the Rayleigh ratio of scattered 
intensity to unpolarized incident light intensity for macromolecules solutions with multi-
component systems is given by (Stockmayer 1950; Kirkwood and Goldberg 1949): 
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here, c1 is the quantity of solvent, Δn represents the change of refractive index, 〈(Δn)2〉 is 
the average of (Δn)2, ci is the concentration of ith component,  b is the total species 
number, µj is the chemical potential of jth component, µ denotes constancy of all chemical 
potentials except  µj and µ1.  
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here weight concentration wi=Mici, Mi is molar mass of the ith scattering species. For 
aggregation, if wtot=∑i wi ,we have 
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Especially, in the case of scattering from a solution of three macromolecule species, eqn. 
2.12 expands to (Minton 2007): 
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where, c1, c2, c3 is the molar concentration of the first, second and third scattering specie, 
respectively.  Δc1, Δc2, Δc3, is the fluctuation of the molar concentration of the first, 
second and third scattering species, respectively. If three species are indexed by i, j, k, 
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here, 
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γi is the thermodynamic activity coefficient of ith species. 
 The equations for Rayleigh ratio of scattered intensity to unpolarized incident 
light intensity for macromolecules solutions with four species can be found in the 
Appendix 1.  
 All the above equations are limited to scattering particles whose sizes are much 
smaller than the wavelength of incident light, such as all the dimensions of particle < 
λ/20. In this work, since the sizes of aggregates (less than 10nm) are much smaller than 
the wavelength of incident light (784nm), the light scattering from large particle is simply 
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stated as follows.  
 
Light Scattering By Large Particles 
 In the case of light scattering by large particles whose size is comparable to the 
wavelength, the Rayleigh ratio will be multiplied by a factor labeled as form factor P(θ). 
In order to obtain expression of form factor, the particle is viewed as containing a large 
number of scattering centers. There is interference between the light scattered by those 
scattering centers. In a particle free to orient itself in any direction,  
   ∑∑=
σ σ
σ
θ
i j ij
ij
qr
qr
P
sin1)( 2                                                      (2.20) 
here, rij is the distance between scattering center i and j, σ is number of scattering centers. 
             
2
sin4 θ
λ
π
≡q
                                        
                       (2.21) 
here, q is the scattering vector, λ is wavelength of incident light in the solution. λ=λ0/n. 
λ0 is the wavelength of incident light in vacuum and n is refractive index of solution (van 
Holde 1985). 
 
Dynamic Light Scattering  
 The dynamic light scattering technique measures the time dependent fluctuations 
in the intensity of scattered light due to Brownian motion of the particles to determine the 
distribution of translational diffusion coefficient, and subsequently the size distribution of 
the particles. The scattering intensity signals are correlated by using an intensity-time 
38 
 
autocorrelator. The resulting correlation function can be used to find the size distribution 
of the particles in the solution. This technique is also known as quasi-elastic light 
scattering and photon correlation spectroscopy.  
 There is a function containing all information about the motion of the scattering 
solute particle. It is defined as, 
            ( )( ))0()(exp),( jjS rrqiqF −⋅≡ ττ                                                 (2.22) 
here, )(τjr is the center of mass position of macromolecule j at time τ, q  is the scattering 
vector, and 〈〉 means the time average (Berne and Pecora 2000). This function is also 
called self-intermediate scattering function by Berne and Pecora. Self-intermediate 
scattering function is the characteristic function of van-Hove self space-time correlation 
function ),( τRGS . 
      ( ) ),(exp),( 3 ττ RGRqiRdqF SS ⋅= ∫                                       (2.23) 
                     ( )( ))0()(),( jjS rrRRG −−= τδτ                                          (2.24) 
here, R is any displacement.  The delta function at the right-hand side of eqn. 2.24 has the 
following values. If displacement )0()( jjj rrr −≡Δ τ is in the neighborhood of the pointR , 
( )( ) 1)0()( =−− jj rrR τδ , otherwise, ( )( ) 0)0()( =−− jj rrR τδ .  
 Because RdRGS
3),( τ  gives the probability of finding a scattering particle in the 
neighborhood Rd 3  of the point R in time τ if the initial position of scattering particle is 
near the neighborhood of origin at time zero and the same probability can also be 
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described by diffusion equation,  ),( τRGS  can be regarded as the solution to the 
diffusion equation: 
         ),(),( 2 ττ
τ
RGDRG SS ∇=∂
∂                                                (2.25) 
here, D is self-diffusion coefficient.  The spatial Fourier transform of eqn. 2.25 is 
    ),(),( 2 ττ
τ
qDFqqF SS −=∂
∂                                                (2.26) 
Solving eqn. 2.26 gives: 
   )/exp()exp(),( 2 qS DqqF ττττ −=−=                                      (2.27) 
here, τq=(q2D)-1 is called the relaxation time and Γ=1/τq=q2D is named as relaxation rate 
or decay rate.  ),( τqFS can be determined from dynamic light scattering, consequently, 
self-diffusion coefficient D will be identified. 
 Once D is known, the hydrodynamic radius RH of the scattering particle, which is 
the radius of sphere that has the same diffusion behavior, can be determined by using the 
Stokes-Einstein equation, 
HR
kT
f
kTD
πη60
==                                                         (2.28) 
where, f0 is friction constant, k is Boltzmann constant, T is the absolute temperature of 
solution, and η is the viscosity of  solution.  
 In dynamic light scattering experiments, the time-dependent scattered intensity is 
measured and sent to autocorrelator. The correlator keeps monitoring the scattering 
intensities in a small time interval for the total measurement time. The scattered intensity 
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is multiplied with itself after it has been shifted by a certain time τ, and these products are 
averaged over the total measurement time. For scattering particles in solution exhibiting 
Brownian motion, the intensity correlation function 〈I(q,t)I(q,t+τ)〉 is related to self-
intermediate scattering function (dynamic structure factor, or electric field correlation 
function) that is discussed before. 
 1
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2 −
+
=+=−= ∗
tqI
tqItqI
tqEtqEDqqFS
τ
τττ                    (2.29) 
Here, E(q,t) is the electric field. The dynamic light scattering signal and intensity 
correlation function are shown in Figure 2.1. 
 In many books, the intensity correlation function is also noted as g2(q, τ): 
 ),(),(),(2 ττ += tqItqIqg                                                  (2.30) 
Correspondingly, the dynamic structure factor is called g1(q, τ).   
)),(1(),( 212 ττ qgBAqg +=                                                (2.31)  
where, A is the measured baseline:  
2),( tqIA =                                                           (2.32) 
and B is a parameter depending on the coherence of the detection. Ideally, B=1.  
 
For monodisperse samples, g1(q, τ) is a single exponential with relaxation rate Γ= 
q2D, but g1(q, τ) becomes a sum of single exponentials when the sample is polydisperse.  
   
∫
∞
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0
2
1 )exp()(),( iii dDDqDGqg ττ
                                         (2.33) 
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Here, G(Di) is distribution function, Di is selfdiffusion coefficient. Since the scattered 
intensity of a given species i is given as, Ii~NiMi2Pi(θ). Ni is number of molecules of 
species i, Pi(θ) is scattering form factor, and Mi is molecule mass. G(Di) depends on Ni, 
Mi, and Pi(θ). If scatters are small or q is small, Pi(θ)~1. 
 Usually, g1(q, τ) is ploted not in a linear scale but in a log-linear or liner-log scale, 
which makes data analysis much easier. An example of g1(q, τ) is shown in Figure 2.2. 
The g1(q, τ)  of pure monomer solution is shown as the dashed line in Figure 2.2. It is a 
straight line in log-linear scale, and single exponential curve in liner-log scale. Figure 2.2 
also shows g1(q, τ)  of three different mixtures. The highest curve is a mixture of 
monomer and 8000mer, which looks like a combination of two lines with different slops 
in log-linear scale and a step-like decay in linear-log scale. The number of steps reflects 
the number of species with different size. However, it is extremely difficult to notice that 
the other two curves actually come from polydisperse solution rather than monodisperse 
solution by judging their shape. It suggests that the difference between sizes of two 
species must be large enough to be distinguished by this method. 
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Figure 2.1. Dynamic light scattering signal and correlation function. The top one shows 
the time-dependent intensity signal measured in dynamic light scattering experiment. The 
bottom one shows the intensity correlation function. 
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Figure 2.2. Log-linear and linear-log plot of g1(τ) for pure monomer and bimodal mixture. 
From highest curve to lowest curve, they are sphere monomer (3nm radius) and 8000mer 
(60nm radius) mixture, sphere monomer (3nm radius) and decamer (6.5nm radius) 
mixture, sphere monomer (3nm radius) and dimer (3.8nm radius) mixture, pure sphere 
monomer (3nm radius) (dash line). All aggregates are treated as spheres.  
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Studying aggregation of hemoglobin by light scattering method can obtain 
information about average molecule weight and average hydrodynamic radius of 
hemoglobin aggregates. Since aggregation is also a hydrophobic force driven process, 
aggregation process can be changed by changing temperature of solution. If we are able 
to study intensity of scattered light at different temperatures, we can get information 
about how the concentrations of aggregates change in the aggregation process. 
Furthermore, information of free energy barrier in nucleation can also be found. By 
comparing aggregation of deoxygenated HbS, oxy HbS, deoxygenated HbA, and oxy 
HbA, we might also have chance to figure out if there is difference between interaction of 
axial and lateral contact.  
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Chapter III: Materials and Methods 
 
Light Scattering Apparatus Design 
 In order to study hemoglobin by using light scattering methods, an apparatus 
needs to be built first. The basic idea of the setup is shown in Figure 3.1. One end of an 
optical fiber is put into a rectangular glass capillary tube that is filled with hemoglobin 
solution. The glass capillary tube is fixed on a sample holder that is placed on the thermo 
control sample stage. The intensity of scatted light is detected at 90° to the incident laser. 
This design has several advantages. 1) A sample only needs 24µl hemoglobin solution. 
Since some species of hemoglobin are not easy to get, the less hemoglobin is needed, the 
more sample can be made. 2) The glass capillary directly contact with stage rather than 
through a water bath that is used in general light scattering system.  This setup allows 
changing the temperature of sample quickly. In order to get as much information as 
possible about aggregation, we want to collect intensity data in a wide as possible 
temperature range. However, at concentrations higher than solubility, deoxygenated 
sickle hemoglobin will start to grow polymers after the temperature of the solution 
exceed a certain value. It requires collecting intensity data to be done as soon as possible 
because what we are interested is nucleation rather than polymerization. Once data is 
obtained, the temperature of the sample will be cooled lower than solubility temperature 
to let polymers dissolve. After all polymers have dissolved, we want to quickly raise the 
temperature of the solution to another high value and get more data. Because this setup 
can make temperature of sample jump back and forth quickly, it allows us to obtain 
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intensity data at more temperatures than that general light scattering system can give.  
 The apparatus is shown in Figure 3.2. The glass capillary tube (Fiber Optic Center 
W3520-050) that is filled with hemoglobin solution is fixed on a specially designed 
sample holder, which is placed on the thermo control sample stage. The thermo controller 
is designed by our group (Cao and Ferrone 1997). In order to monitor the temperature of 
sample, the sample holder is also equipped with a thermocouple (Omega DP25B-TC) 
which is placed in the same condition as the hemoglobin sample. Light provided by diode 
laser (Sanyo DL7140_201S) shines in a collimator connected with one end of the optical 
fiber (Thorlabs GIF625) whose another end is put into the glass capillary tube. Two long 
working distance objectives are used as condenser and objective.  They are objective A 
(Leitz ×32), and objective B (Ealing reflecting objective ×15). Scattered light is collected 
by photomultiplier tube (PMT, Hamamatsu R636) at 90° to the incident laser. The PMT 
output signal will be transferred to computer by a digital storage oscilloscope (Syscomp 
electronic design DSO-101). For absorption spectrum measurements, the light is provided 
by a xenon lamp. The absorption spectrum will be collected by a spectrometer (Ocean 
optics USB4000). The pinhole, which is conjugate to the back focal plane of the collector 
objective, is used to control the scattered light to enter the PMT window. Two 
diaphragms, which are conjugate to the sample plane, are used to restrict the detected 
area of the sample. A grid eyepiece is mounted behind the objective B for helping adjust 
the sample position, and change the aperture of diaphragm. Because the fiber end moves 
irregularly about 1~5µm sometime if the temperature of the sample is changed, it will 
change the relative position between the fiber end and the edges of the diaphragm that are  
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Figure 3.1. A schematic of the basic idea of the setup. One end of an optical fiber is put 
into a glass capillary tube that is filled with hemoglobin solution. The laser beam that 
comes out of the end of optical fiber is scattered by the hemoglobin solution and 
collected at 90°. The rectangle drawn in black dashed line shows the observation window.  
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Figure 3.2. A schematic of the apparatus. One end of an optical fiber (green line) is put 
into a glass capillary that is filled with hemoglobin solution. The glass capillary tube is 
fixed on a sample holder which is placed on the thermo control sample. The intensity of 
scatted light (red line) is detected by PMT at 90° to the incident laser. The PMT output 
signal will be transferred to computer by digital storage oscilloscope (DSO). The mirrors 
that are represented by three lines symbol are mounted on slide rails and can be moved as 
needed in the experiment. The mirrors that are described by thick lines are not designed 
to be moved in the apparatus. For absorption spectrum measurement, the mirror C will be 
moved, which allows the light (black dashed line) provided by a xenon lamp shining in 
the sample. The absorption spectrum will be collected by spectrometer. The pinhole, 
which is conjugate to the back aperture of the collecting objective, is used to control the 
scattered light that can be allowed to enter the PMT window. Two diaphragms, which are 
conjugate to the sample, are used to restrict the detected area of the sample.  
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Figure 3.2(continued). 
A grid eyepiece is mounted behind the objective B for helping locate the optical fiber 
position, and change the aperture of diaphragm. While collecting scattered intensity, 
mirror E is moved away. Every time while waiting for temperature of solution going to 
the set value after one measurement is done, mirror E will be put back to the optical path, 
which allows the light coming out of diode laser to be reflected into the Si switchable 
gain detector (Thorlabs PDA100A) to make sure the intensity of laser remains constant. 
The probe light is also provided by monochromator.  
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used as boundaries of the detected region. This relative movement between the edges of 
diaphragm and the fiber end will change the scattering volume, or explore the fiber end in 
the detected region directly, which will greatly change the intensity measurements. In 
order to get good intensity signal, there are many parameters of the apparatus that need to 
be determined.    
 
Kőhler Illumination 
 After being designed by August Kőhler in 1893, Kőhler illumination become a 
critical illumination technique that provides optimum resolution and contrast in a 
microscope. The collector lens, which is put between light source and condenser, can be 
adjusted to focus an image of the lamp filament at the front focal plane of condenser. 
Because of that, the condenser projects rather than focuses light through the sample. 
Since the objective has an optically symmetric position with condenser, the light filament 
is also conjugate with the back focal plane of objective, as well as the pupil of the eye 
after light passes through eyepiece. In other words, the lamp filament has three conjugate 
planes. The field diaphragm is conjugate with the sample plane. The objective focuses an 
image of a sample in front of eyepiece. That image will finally be focused at the retina by 
eye. So, the sample plane also has three conjugate planes. Since the lamp filament is 
focused at the front place of condenser, each source point contributes equally to 
illumination in the sample plane. Under Kőhler illumination, the sample plane is 
illuminated even and brightly. Any point in the sample will be illuminated by every point 
of lamp filament (Piller 1977, Murphy 2001).  
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 Kőhler illumination is also critical in the absorption spectrum measurement 
because different regions in the sample should be illuminated by the same light source 
during the measurement. While taking absorption spectrum, a collector lens is placed at 
the position where eyepiece is in a microscope, and the spectrometer takes the place of 
observer.  Not only is the field diaphragm conjugate with the sample plane, but also is 
placed at the back focal plane of the collector lens. This setup is necessary because the 
following reason. In the case of measuring the absorption spectrum of a part of the 
sample instead of the total illuminated sample, the field diaphragm is also used to restrict 
the detected sample region. Only if the field diaphragm is placed at the back focal plane 
of the collector lens, the regular illumination of sample will not be destroyed while 
opening and closing field diaphragm.  The position of photocathode of PMT is also 
conjugate with the back focal plane of the lens that is in front of it, which keeps all the 
scattered light shining on the PMT as long as the sample is in the stage plane. This setup 
will save some experiment time during data collecting. If the position of photocathode of 
PMT is at the sample’s image plane, you have to be sure that the center of scattering 
region is at the exact optical center at every time when a new sample is mounted on the 
sample stage. Otherwise, if the center of scattering region is off, consequently, the optical 
center of system the image of sample will also be off the expecting position, which might 
cause losing some scattered light without being noticed.  The Kőhler configuration in the 
apparatus of this work is shown in Figure 3.3. To ensure the apparatus is in Kőhler 
configuration, the optic centers of all the lens and objectives should be at same height and 
share the common optical axis. This can be checked by using following method. Put a  
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Figure 3.3 Kőhler configurations of apparatus. Objective A works as condenser when 
taking an absorption spectrum, but works as objective when collecting scattered light at 
90°. To take absorption spectrum, diaphragm A works as field diaphragm. Left graph 
shows the conjugate field planes in the apparatus. Diaphragm A, the sample plane, 
diaphragm B and the spectrometer/retina are conjugate with each other. Diaphragm A is 
also in the back focal plane of collecting lens. The right graph shows conjugate the 
aperture planes in the apparatus. Lamp filament, the front focal of objective A, the back 
focal plane of objective B and the iris diaphragm of eye are conjugate with each other. 
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laser at the same optical position of lamp filament, and replace the spectrometer with a 
vertically mounted mirror. The laser should be reflected back to the exactly emitting 
point if the setup was good. To set all the conjugate planes in the right positions, a phase 
telescope can be used to locate the image of lamp filament. The phase telescope 
temporarily replaces the eyepiece that is behind the diaphragm B.   
 
Limitation of Intensity of Laser Determination 
 When the hemoglobin solution is illuminated by laser, the temperature of 
hemoglobin solution can increase because hemoglobin absorbs light. Although laser 
heating cannot be avoid, the influence due to laser heating can be declined to a reasonable 
extent by restricting the intensity of laser within a certain value below which the sample’s 
temperature increase caused by laser heating is tolerable. 
 As a pH indicator, the extinction coefficient of cresol red solution is sensitive to 
the pH value of solution. Because the pH value of Tris buffer is sensitive to the buffer 
temperature, the change of temperature of buffer will be clearly reflected by the change 
of optical density of the cresol red in Tris buffer, which makes cresol red in Tris buffer an 
excellent dye sample for determining the limitation of intensity of laser (Ferrone et al., 
1985a).  
 The optical density (OD) of the solution at a certain wavelength λ is given by: 
)/log( 0IIOD −=                                                     (3.1) 
here, I is intensity of transmitted light and I0 is intensity of incident light. 
                    cLOD ε=                                                                   (3.2) 
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where, ε is extinction coefficient, c is molar concentration of sample, and L is light path.  
 The relation between the extinction coefficient of dye and temperature is 
established in the following way. Concentrated dye solution, 0.1M solution of cresol red 
in 1.0M Tris·Hcl (pH 8.0 at room temperature), was made. Then, in order to get proper 
OD in absorption measurement, concentrated cresol red solution was diluted to  
3.74×10-5M. After that, a 10mm light path length quartz cuvette (Fisherband quartz 
standard cells) containing the dilute solution was immersed into a water bath at desired 
temperature. After waited long enough for the temperature of solution reaching the 
equilibrium with the temperature of water, the cuvette was loaded into a 
spectrophotometer (Hewlett Packard model 8452A) for absorption spectrum 
measurement. The temperature of solution was measured immediately after absorption 
spectrum had been taken. After that, the temperature of dye was changed to the next 
desired value and the corresponding absorption spectrum was measured. The relation 
between the extinction coefficient of dye and temperature in the visible region is shown 
in Figure 3.4 and 3.5. Because the dye has relative small extinction coefficient at our 
working wavelength (784nm), a Diode-pumped solid state laser (532 nm, LambdaPro 
UGA-300MW) rather than diode laser (784nm, Sanyo DL7140_201S) was used in this 
control experiment. The extinction coefficient of dye at 532nm is 15028.68M-1cm-1, and 
the extinction coefficient of hemoglobin at 784nm is 996.72 68M-1cm-1. The 1.87mM dye 
solution was loaded into the glass capillary tube, which is fixed on the sample holder that 
is in sample stage. The inside length of the glass capillary tube is 200µm. By monitoring 
the OD of dye solution while changing the intensity of laser, the maximum intensity of  
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Figure 3.4 The relation between the extinction coefficient of dye and temperature in the 
visible region. The extinction coefficient of dye in the visible region at 18.4°C (black), 
20.1°C (red), 22.0°C (blue), 24.3°C (purple), 26.1°C (dark yellow), 27.8°C (green).  
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Figure 3.5. The relation between the extinction coefficient of dye and temperature at 
574nm (triangle) and 532nm (circle). The peak of extinction coefficient of dye is at 
574nm and the wavelength of laser that is used in the laser heating control experiment is 
532nm. The lines represent the fitting curve, ε=36.99(±0.15)−0.43(±0.01)×T mM-1cm-1, 
at 574nm, and ε=19.19(±0.07) −0.21(±0.01)×T mM-1cm-1, at 532nm. 
57 
 
laser that is allowed in hemoglobin light scattering experiment without overheating the 
sample was found. The result is that the sample’s temperature increase due to laser 
heating is no more than 0.2°C as long as the intensity of laser is less than 2mW.   
 
Measurement of Distribution of Scattered Intensity 
 During collecting scattered light intensity, the region of interest can be chosen by 
changing the size and the position of aperture opened in diaphragm A.  It is necessary to 
set up a common size for the detected window for all of light scattering experiments, so 
that the scattering volume for all of the experiments will be same.  The larger the window 
is, the stronger scattered intensity signal is collected. In order to decide the size of the 
detected window, distribution of scattered intensity need to be measured. The distribution 
of scattered intensity is measured in the following way.  
 We used 8.4g/dl deoxygenated hemoglobin S solution as the sample for this 
control experiment. First, we chose the sample plane as x-y plane, and set the y axis 
parallel to the direction of incident light, and then z axis would be along the direction in 
which scattered light is collected. One of edges of the diaphragm was moved to the 
position where the fiber end could be just blocked by the edge’s image, and the 
symmetric edge was moved until the images of those two edges were just 140µm far 
from each other. The positions of the other two edges that were perpendicular to the 
previous edges were adjusted to make a 140µm×10µm detected window in the sample 
plane. We set the center of cross section of optical fiber as the original of this coordinate. 
This detected window was moved along x axis in a 10µm step, and scattered intensity 
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was collected every time. This gave the distribution of scattered intensity along x axis, 
with the length of optical path 140µm. The result is shown in Figure 3.6.  We repeated 
the above procedure with another detected window in dimension 320µm×10µm. The 
result is also shown in Figure 3.6. The reason for choosing 140µm and 320µm as 
detected window size is as follows. The optical fiber (GIF625) has numerical aperture 
0.27, cladding 125µm in diameter, and core 62.5µm in diameter.  The refractive index of 
the sample is 1.34 at 784nm (Friebel and Meinke 2005, 2006). Calculation show that the 
diameter of the light cone coming out of optical fiber becomes 125µm (same as the 
cladding diameter) at the position 145µm away from the end of optical fiber and is 
200µm, which is the same as inside length of glass capillary tub, at the position 320µm 
away from the end of optical fiber. The geometry is also shown in Figure 3.6. Data show 
that in the case of detected window with length 140µm, 97% of the scattered intensity is 
within an area whose width is less than the diameter of optical fiber core (62.5µm), and 
all the scattered intensity coming from the area with width 125µm. When the detected 
window has length 320µm, 99% of the scattered light comes from an area with width 
125µm, which is also the diameter of optical fiber cladding, and all the scattered light 
comes from the area with width 180µm.  Considering that the end of the optical fiber will 
possibly contact with one inner side of glass capillary tube rather than staying in the 
middle of the glass capillary tube without contacting with any of the inner sides of 
capillary tube, which is hard to be avoided, then using 140µm as the length of detected 
window will be the better choice because all the scattered light collected in that window  
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Figure 3.6. Distributions of intensity of scattered light. The glass capillary tube is shown 
in light blue, the cladding of optical fiber is in dark blue, and the core of optical fiber is in 
green. The detected area is divided into many small identical parts. Each of them has 
dimension either 140µm×10µm (top graph), or 320µm×10µm (bottom graph). Each black 
column stands for intensity of light scattered from one of parts. The center of optical fiber 
is set at the original of x axis. Orange regions show geometry of the light cone coming 
out of optical fiber. Top graph shows intensity of scattered light when the dimension of 
detected window is 200µm×140µm. Bottom graph shows intensity of scattered light 
when the size of detected window is 200µm×320µm.  
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comes from an area illuminated by an intact light cone. This will avoid potential risks 
caused from incident light hitting on the wall of glass capillary tube. Corresponding to 
140µm in length, 200µm is large enough to be the width of detected window.  
 
Polarization State of Incident Light 
 Polarization state will be changed after the laser beam emerges out of optical fiber. 
Since there was no polarization controller being used in the apparatus, it is necessary to 
study how the polarization state changes after optical fiber. This control experiment was 
done as follows. A Si switchable gain detector (Thorlabs PDA100A) was used as the 
intensity detector. After mounting a sheet polarizer film vertically between the intensity 
detector and the laser, we matched the polarization axis of laser and that of polarizer film. 
The intensity of the laser was measured once polarizer film is rotated every 22.5° along 
the axis connecting detector and laser, until polarizer film was rotated 360° relative to the 
original position. The data is shown in Figure 3.7. Following the same procedure, we 
obtained the intensity of light coming out of fiber as a function of angle between the 
polarization axis of polarizer film and the polarization axis of laser. The data is also 
shown in Figure 3.7. We put the optical fiber into an empty glass capillary tube through 
one end, and left the other end open so that all the light coming out of optical fiber can 
directly shine on the intensity detector.  We mounted the glass tube and fiber on the 
sample holder while keeping all the other setup same as if we were actually measuring  
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Figure 3.7. Changes in polarization state of light coming in or out of optical fiber. 
Intensity of laser is shown in solid circle; intensity of light coming out of the fiber with a 
free end is in triangles; intensity of light coming out of fiber put in the empty glass 
capillary tube is shown in open circles. The fitting curve of intensity of laser is shown in 
the dotted line (I=0.92·sin2(θ−93.9°)+0.08). The fitting curve of intensity of light coming 
out of the fiber with a free end is shown in the solid line (I=0.25·sin2(θ−111.4°)+0.74). 
The fitting curve of intensity of light coming out of fiber put in the empty glass capillary 
tube is shown in the dashed line (I=0.24·sin2(θ−129.6°)+0.76). 
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the scattered intensity of hemoglobin solution. We removed the polarizer film from the 
previous position to the new position that was between intensity detector and the end of 
optical fiber, and then repeated the measurement. The data is shown in Figure 3.7.   
 The result shows that polarization state of light does change when laser passes 
through optical fiber, and the polarization state is also changed when optical fiber is in 
working condition. The incident light is more like unpolarized light than polarized light. 
 
PMT Gain Calibration 
 In order to get the value of absolute intensity of scattered light in units Watts 
instead of direct output of PMT, the gain of PMT needs to be calibrated. PMT gain 
calibration was done by comparing output signal of PMT under certain supply voltage 
with output signal of Si switchable gain detector (PDA100A) when both of them were 
used to measure the intensity of scattered light from the same sample. The intensity of 
laser was temporarily raised to 12mW for this control experiment because the gain of 
PDA100A was too small to get signal if the intensity of laser was set at working intensity 
(less than 2mw). The relative gain of PMT as a function of PMT supply voltage was also 
measured and shown in Figure 3.8. 
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Figure 3.8. The relative gain of PMT as a function of PMT supply voltage. The gain of 
PMT is shown in solid circles and the fitting curve is shown in solid line. The gain of 
PMT is set to 1 at 600V that is PMT’s working supply voltage when it is calibrated by 
using PDA100A. 
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Hemoglobin Concentration, Sample Quality and Stability Determination 
 For each sample, several micro liter hemoglobin solution was saved for final 
concentration determination while the rest of the solution was filled in the glass capillary 
tube to make sample. The saved solution was diluted with CO saturated 0.15M phosphate 
buffer (pH7.35) in a ratio. The final concentration of the hemoglobin sample was 
determined by measuring the Soret region (400-450nm) of the absorption spectrum of a 
diluted sample in a 10mm path length quartz cuvette (Fisherband quartz standard cells) 
with a spectrophotometer (Hewlett Packard model 8452A). The recorded spectrum was 
analyzed by error-weighted linear curve fitting to standard spectra, which allowed 
determining the final hemoglobin concentration of the sample (Ferrone et al., 1985c). The 
Soret absorption spectrum of a diluted sample and its fitting curve were shown in Figure 
3.9. 
 The sample quality and stability was checked by analyzing absorption spectrum in 
the visible range (500-650nm), performed directly on the sample while it was in the glass 
capillary tube before and after each experiment.  The absorption spectrum was taken by 
using a spectrometer (Ocean Optics USB4000), which was a part of the apparatus. 
Although absorption of hemoglobin in the visible region (500-650nm) is much smaller 
than that of in Soret region, optical densities of the samples at some wavelengths were 
very high (above 1.5) because samples were concentrated hemoglobin solution and the 
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inner side length of glass capillary was 200µm. For each sample, only the part of 
absorption spectra whose optical densities were smaller than 1.5 were used in the sample 
quality determination. Because differences in absorption spectra among different 
hemoglobin derivatives (met, oxy hemoglobin, deoxygenated hemoglobin, HbCO) were 
distinguishable enough, sample quality could still be well examined. The visible region of 
absorption spectrum of a sample and its fitting curve are also shown in Figure 3.7. That 
deliberately made bad sample was shown consisting of 23.6% met, 34.4% oxy 
hemoglobin and 41.9% deoxygenated hemoglobin. The above two analyzing codes were 
written by our group.  
 There were no changes in the absorption spectra of samples within 24-72 hours 
after samples were made.  After that, small amount of methemoglobin started to appear 
and the amount of methemoglobin kept increasing.  The intensity of scattered light of all 
the samples was measured within 15 hours after sample was made. 
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Figure 3.9. The absorption spectra of hemoglobin samples. (a) The absorption spectrum 
of a sample diluted with CO saturated 0.15M phosphate buffer (pH7.35). It was a general 
spectrum for sample concentration determination. (b) The Soret region of spectrum is 
shown in (a). Solid circle shows the measured spectrum, and line shows fitting curve. The 
diluted sample always consists of nearly 100% HbCO, despite of what kind of 
hemoglobin derivatives are in original sample. (c) The absorption spectrum of a 
deliberately made bad sample in glass capillary tube. The spectrum in Soret region looks 
bad because OD in Soret region is so high that it exceeds the detected limitation of 
spectrometer.   (d) The visible region of spectrum shown in (c). Solid circle shows the 
measured spectrum, and line shows fitting curve. Result shows that the sample consists of 
23.6% met, 34.4% oxy hemoglobin and 41.9% deoxygenated hemoglobin. 
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Sample Purification and Preparation 
 The sickle cell blood was provided by the Children’s Hospital of Philadelphia. 
Hemoglobin was purified by using column chromatography. The procedures (Williams 
and Tsay 1973) have been modified by our group and are shown in Appendix 2. The 
buffer of hemoglobin needs to be changed from Tris buffer to 0.15M phosphate buffer 
(pH 7.35) for the final use. The buffer exchange was done by making hemoglobin 
solution pass through a desalting column (Amersham PD10, 9 ml column of Sephadex G-
25m) prewashed by phosphate buffer. The phosphate buffer kept running through the 
desalting column all the time during buffer exchange. After that, the hemoglobin was 
concentrated with Centricon (Corning Spin-X 20ml) to the proper concentration for 
storage. The integrity of sickle hemoglobin was verified by one of our group members, 
Donna Yosmanovich. Then, the hemoglobin was stored in liquid nitrogen as the oxy 
derivative until use. The cross linked normal hemoglobin and part of sickle hemoglobin 
was obtained from Albert Einstein College of Medicine.  
 The preparation of a deoxygenated sample was done in a glove refrigerator, 
through which water-saturated nitrogen was flowed. The detailed procedure is as follows. 
On the day before preparing sample, after washing the sample holder and the glass 
capillary tube, they were dried with compressed nitrogen. One end of glass capillary tube 
was sealed with dental wax (Kerr sticky) and left in a refrigerator until the wax become 
cold. If no crack was found in wax after it became cold, the glass capillary tube was 
ready to use. Otherwise, the glass capillary was resealed and the previous step was 
repeated until the seal was intact at both low temperature and room temperature. This 
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step is necessary because the temperature of glass capillary tube will be changed from 
3°C to 30°C during experiment for deoxygenated sample at high concentration, and from 
15°C to 43°C during experiment for other deoxygenated sample and HbCO.  The optical 
fiber was prepared after the glass capillary tube was ready. First, we carefully removed a 
10cm long cable jacket from the free end of optical fiber with a cable slitter.  Second, we 
removed 5cm long coating material from the end of the optical fiber by using stripping 
tool (Micro Electronics micro-strip .006). There should be absolutely no residue of 
coating material remaining on the cladding surface of optical fiber because any defect on 
the cladding surface might let tiny air bubbles stick on it while fiber end is plugged into 
the glass capillary tube after it is filled with hemoglobin solution. Next, we cut the end of 
optical fiber with field fiber cleaver (Furukawa Fitel S-315). The fiber end does not have 
to be polished, but it should be as close as possible to perpendicular to the fiber axis. A 
microscope is used to check if the fiber end is sharp enough. If not, we kept cutting until 
a good sharp end is achieved. The length of the fiber end without coating part should be 
in a proper value (16mm for this particular sample holder) that makes the fiber end close 
to the optical center of apparatus when the sample is placed on the sample stage. After 
the fiber end was washed and dried with compressed nitrogen, we moved the optical fiber, 
the sample holder, and the glass capillary tube into the glove refrigerator.  
 On the day for making the sample and measuring intensity of scattered light, we 
brought a small container with ice cold water and another container with 30ml phosphate 
buffer (all the phosphate buffer mentioned in this work is 0.15M phosphate buffer at pH 
7.35) into the glove refrigerator. We flushed the glove refrigerator with water saturated 
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nitrogen for 1 hour, and then flushed phosphate buffer for 1 hour. While waiting for 
flushing to be done, we moved concentrated hemoglobin solution as needed out of liquid 
nitrogen and measured the concentration of hemoglobin solution after it was thawed. The 
concentration is determined by using the spectrometric method described above. We 
calculated the amount of sodium dithionite (Na2S2O4) needed to make solution with 
which concentrated hemoglobin solution can be diluted to the experimental desired 
concentration while concentration of sodium dithionite in solution is also 0.05M. After 
flushing is over, we brought concentrated hemoglobin solution and sodium dithionite into 
the glove refrigerator and start to make sample. During the process of making the sample, 
any leakage will possibly ruin the sample because hemoglobin has high affinity to bind 
with oxygen. Although sodium dithionite will bind with oxygen before hemoglobin, too 
much oxygen will saturate the binding ability of sodium dithionite. The concentration of 
sodium dithionite cannot be too high because the pH value of buffer will change after too 
much sodium dithionite bound with oxygen. 
 We mixed 2ml nitrogen saturated phosphate buffer with sodium dithionite. We 
cooled down the sodium dithionite solution by immersing the vial into cold water. We 
then aspirated a certain amount of cold sodium dithionite solution with micro-dispenser 
pipette (Drummond) and mixed it with certain amount of cold concentrated hemoglobin 
solution until the final desired sample concentration with 0.05M sodium dithionite was 
reached. If gel appeared during mixing process, we cooled down the hemoglobin solution 
by immersing the vial into cold water and waited 20 minutes. All samples and solutions 
used should previously be filtered with 0.2µm filters (Whatman). All water was double 
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distilled water previously filtered with 0.2µm filters (Whatman). We used micro-
dispenser pipette to transfer hemoglobin solution into glass capillary tube until it is full. 
After fix glass capillary tube on the sample holder, we carefully and gently plugged the 
end of the optical fiber into the glass capillary tube. We would try not to let fiber end 
touch any surface especially the end of glass capillary tube that has pretty thin wall. 
Although the fiber end will not be contaminated since all the surfaces are clean, the fiber 
end might not be sharp enough if it is worn. After the fiber end was in the right position 
in the glass capillary tube, we sealed both ends of the glass capillary tube with dental wax 
and fasten fiber on the sample holder. We use the rest of hemoglobin solution to indentify 
the final concentration of hemoglobin solution by using the spectrometric method 
described above. The final concentration should be consistent with the desired value. 
Otherwise, a new sample needs to be made. After that, we mounted the sample holder on 
the sample stage, and checked the quality of the sample by measuring the absorption 
spectrum of sample directly. We checked the image of sample, and there should be no air 
bubble in the solution and on the surface of the fiber end. If everything is good, the 
sample is ready.  
 The preparation of a CO sample was done in a glove box, through which water-
saturated carbon monoxide was flowed. The procedures are the same as preparation of a 
deoxygenated sample. 
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Chapter IV: Results 
  
 25 hemoglobin samples were studied in this work. All the hemoglobin samples 
came from 5 different species, which were deoxygenated HbS, HbSCO, deoxygenated 
HbA, HbACO and deoxygenated cross-linked normal hemoglobin (deoxygenated XLA). 
The concentration of hemoglobin samples ranged from 7.7g/dl to 33.4g/dl.  
 If the sample was made of the non-polymerizing hemoglobin derivatives, such as 
HbA, cross-linked HbA, HbSCO, and deoxygenated HbS whose concentrations were 
lower than solubility of deoxygenated HbS, the first data point of the intensity of 
scattered light was usually taken at room temperature. And then, after the temperature of 
the sample was decreased to 15°C, we started to raise the temperature of the sample at 
3°C intervals. While waiting for the temperature of the sample to approach the desired 
value, the intensity of laser was checked in case it varied. Once the temperature of the 
sample didn’t vary more than 0.1°C within 2 minutes after it reached the desired value, 
the location of the fiber end was examined by using the grid eyepiece built in the 
apparatus. The fiber end was moved back to its original position if the location of the 
fiber end moved relative to the images of the edges of diaphragm that were used as 
boundaries of the detected region. Because the fiber end moved irregularly about 1~5µm 
sometime after the temperature of sample was changed, the relative movement between 
the edges of diaphragm and the fiber end would change the scattering volume, or expose 
the fiber end in the detected region directly, which would greatly change the intensity 
measurements. And then, the intensity of scattered light of the sample was collected. The 
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temperature of the sample was increased at 3°C intervals until the intensity of scattered 
light of the sample started to increase. After that, the temperature of the sample was 
raised at 1°C intervals. During the entire experiment, every two times after we raised the 
temperature of the sample, we decreased the temperature of the sample to a value that 
was lower than those two temperatures.  After the intensity data was taken, we started to 
raise the temperature of the sample again. The procedure was repeated until the sample 
reached its highest temperature, which was 43°C for the HbA and HbSCO samples, or 
52°C for the cross-linked HbA samples. After that, the procedure was repeated in 0.5°C 
intervals from the value 2°C below where the intensity of scattered light started to 
increase to the highest temperature. 
 If the sample was made of deoxygenated HbS whose concentration was high 
enough to grow polymer, at temperatures in the range studied, the first intensity of 
scattered light was taken at a temperature that was lower than the solubility temperature 
of the sample. The first temperature was usually at 5°C, or 3°C if 5°C was not low 
enough to be below solubility. And then, the same procedure that was used in taking data 
for non-polymerizing sample was followed. After all the desired temperatures that were 
lower than the solubility temperature of the sample had been reached, the temperature of 
the sample was raised to above the solubility temperature of the sample. Once the 
temperature of the sample didn’t vary more than 0.1°C within 15 seconds after it reached 
the desired value, the location of the fiber end was examined immediately and the 
intensity of scattered light of the sample was taken. If the temperature of the sample did 
vary more than 0.1°C while collecting the intensity of scattered light, the average of the 
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temperature during collecting process was used as the final temperature for this data. The 
location of the fiber end was reexamined after data was collected. If the location of the 
fiber end didn’t move during collecting, the data was finally saved; otherwise, the data 
was discarded. Then, the temperature of the sample was decreased to a value lower than 
the solubility temperature of the sample to let polymers dissolve because polymers might 
appear in the sample while the temperature of the sample was above the solubility 
temperature of the sample. The intensity of scattered light would not drop back to the 
normal level immediately after the temperature of the sample was lowered from the high 
value to the low value, but slowly. We waited until the intensity returned to the original 
level. Usually, it took 20~90 minutes. The waiting time depended on the temperature that 
the sample reached and the time that the sample stayed after the sample reached that 
temperature in the previous step. The higher the temperature of sample or the longer the 
sample stayed at that temperature, the longer waiting time was needed. After the intensity 
returned to the normal level, the temperature of the sample was raised again. The 
procedure was repeated until the intensity was not able to drop back to its original level 
within 120 minutes after the sample was cooled at a temperature lower than its solubility 
temperature or the highest temperature of the sample was reached. The highest 
temperature of the deoxygenated sample was chosen as that at which the tenth-time of 
hemoglobin was ~180 seconds at the sample’s concentration.  
 The intensity of scattered light as a function of temperature of each sample is 
shown in each of the following graphs, respectively. Every point in each graph represents 
the average of 16000 intensities recorded by a digital storage oscilloscope (DSO-101) in 
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1 minute. Not all of the data measured in each experiment are qualified to be used for 
drawing the graph because the baseline of intensity may shift during collecting. The 
criterion is as follows. For each temperature, at first, all those 16000 intensities were used 
to draw a graph showing the intensity as a function of time within one second. Then, a 
linear fitting was generated by using all those 16000 intensities data. Next, the intensities 
at time zero and at time 1 minute were calculated by using parameters obtained from 
linear fitting. If the difference between those two intensities was larger than 15%, all of 
those 16000 intensities data at this temperature were discarded. 37 out of 541 
temperatures were discarded by this criterion. The number of data discarded and total 
data measured is shown in last column of Table 4.1. 
 In Figure 4.1-18, solid circles represent the intensity of scattered light measured in 
light scattering experiments, and the solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c.  Here IS depicts intensity of scattered light in units of nW, T is the 
temperature of solution in unit °C, and a, b, c are fitting parameters. There are straight 
vertical dashed lines in some of graphs. Those graphs are for hemoglobin samples that 
can make polymers. The dashed lines show the solubility temperature at the 
concentration of hemoglobin sample. In those graphs, only the scattered intensity data 
below the solubility temperature have been used in finding the fitting parameters. All the 
fitting parameters are shown in Table 4.1. The intensities of incident light for all the 
samples were normalized to 1mW and the actual values used in experiments are also 
shown in Table 4.1. All the scattered intensity data have error bars. In some graphs, error 
bars cannot be seen only because the error bars are smaller than the solid circles.  
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Figure 4.1. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 7.7g/dl and 8.4g/dl. The solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c. 
 
 
 
76 
 
 
 
15 20 25 30 35 40 45
0.3
0.4
0.5
0.6
0.7
0.8
 11.2 g/dl deoxygenated HbS
I S
 (n
W
)
 T(°C)
10 15 20 25 30 35 40
0.5
0.6
0.7
0.8
0.9
1.0
 14.7 g/dl deoxygenated HbS
I S
 (n
W
)
 T(°C)
 
Figure 4.2. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 11.2g/dl and 14.7g/dl. The solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c. 
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Figure 4.3. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 15.7 g/dl and 16.8g/dl. The dashed lines show the solubility temperature 
at the 16.8g/dl. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.4. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 17.4 g/dl and 17.8g/dl. The dashed lines show the solubility temperature 
at that concentration. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.5. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 19.5 g/dl and 19.7g/dl. The dashed lines show the solubility temperature 
at that concentration. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.6. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 20.2 g/dl and 20.8 g/dl. The dashed lines show the solubility temperature 
at that concentration. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.7. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 22.7 g/dl and 23.0 g/dl. The dashed lines show the solubility temperature 
at that concentration. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.8. Intensity of scattered light as a function of temperature for deoxygenated HbS 
at concentration 23.6 g/dl and 26.9 g/dl. The dashed lines show the solubility temperature 
at that concentration. The solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.9. Intensity of scattered light as a function of temperature for HbSCO at 
concentration 15.9 g/dl and 33.2 g/dl. The solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c. 
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Figure 4.10. Intensity of scattered light as a function of temperature for HbACO at 
concentration 15.7 g/dl and 33.4 g/dl. The solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c. 
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Figure 4.11. Intensity of scattered light as a function of temperature for deoxygenated 
cross-linked HbA (deoxygenated XLA) at concentration 14.1 g/dl and 29.0 g/dl. The 
solid line stands for the fitting curve in form IS=a·exp(b·T)+c. 
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Figure 4.12. Intensity of scattered light as a function of temperature for deoxygenated 
HbA at concentration 11.4g/dl and 28.3 g/dl. The solid line stands for the fitting curve in 
form IS=a·exp(b·T)+c. 
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Figure 4.13. Intensity of scattered light as a function of temperature for deoxygenated 
HbA at concentration 33.3 g/dl. The solid line stands for the fitting curve in form 
IS=a·exp(b·T)+c. 
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 Table 4.1 Fitting parameters of hemoglobin samples and intensity of incident light 
Sample Hemoglobin c(g/dl) a b Δb c Δc I0(mW) D/T∗ 
1 deoxygenated HbS 7.7 1.62E-03 0.11 0.06 0.39 0.04 1.61 1/19 
2 deoxygenated HbS 8.4 1.26E-03 0.11 0.06 0.43 0.03 1.57 0/23 
3 deoxygenated HbS 11.2 2.40E-02 0.05 0.14 0.45 0.38 1.75 0/12 
4 deoxygenated HbS 14.7 5.66E-04 0.18 0.19 0.66 0.09 1.72 0/11 
5 deoxygenated HbS 15.7 7.36E-05 0.21 0.07 0.62 0.03 1.72 0/19 
6 deoxygenated HbS 16.8 1.09E-03 0.18 0.06 0.34 0.02 1.46 1/25 
7 deoxygenated HbS 17.4 2.80E-02 0.11 0.06 0.60 0.09 1.45 0/23 
8 deoxygenated HbS 17.8 3.74E-02 0.09 0.17 0.55 0.05 1.56 3/26 
9 deoxygenated HbS 19.5 3.19E-02 0.12 0.10 0.52 0.13 0.99 0/24 
10 deoxygenated HbS 19.7 2.15E-02 0.14 0.09 0.53 0.11 1.72 0/28 
11 deoxygenated HbS 20.2 1.35E-02 0.14 0.55 0.52 0.33 1.72 5/26 
12 deoxygenated HbS 20.8 8.64E-03 0.17 0.66 0.36 0.31 1.7 6/27 
13 deoxygenated HbS 22.7 2.21E-02 0.19 0.76 0.57 0.54 1.72 4/20 
14 deoxygenated HbS 23.0 1.65E-04 0.64 7.84 0.54 0.79 1.73 0/16 
15 deoxygenated HbS 23.6 2.09E-02 0.16 2.02 0.31 1.06 1.75 1/23 
16 deoxygenated HbS 26.9 4.45E-02 0.20 2.92 0.32 1.66 1.46 4/26 
17 HbSCO 15.9 2.36E-07 0.30 0.11 0.24 0.01 1.61 0/33 
18 HbSCO 32.2 3.25E-08 0.35 0.09 0.17 0.01 1.65 0/22 
19 HbACO 15.7 1.13E-05 0.19 0.18 0.29 0.01 1.51 0/19 
20 HbACO 33.4 2.22E-04 0.16 0.15 0.16 0.04 1.51 0/15 
21 deoxygenated XLA 14.1 3.13E-07 0.29 0.09 0.38 0.01 1.51 4/21 
22 deoxygenated XLA 29.0 3.09E-03 0.10 0.16 0.47 0.25 1.51 2/19 
23 deoxygenated HbA 11.4 5.58E-08 0.28 0.31 0.15 0.01 1.51 1/28 
24 deoxygenated HbA 28.3 5.61E-07 0.30 0.16 0.20 0.01 1.51 4/17 
25 deoxygenated HbA 33.3 1.56E-04 0.17 0.09 0.16 0.03 1.51 1/19 
 
∗ D/T means the ration of the number of discarded data to total data 
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Figure 4.14. Intensity of scattered light (top) and reciprocal of intensity of scattered light 
(bottom) as a function of temperature of HbACO at 33.4g/dl. The spinodal temperature 
TS was determined from extrapolation of I-1 from light scattering. Dashed line shows 
fitting curve of I-1. The same curve is also shown in intensity space. 
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Figure 4.15. Intensity of scattered light (top) and reciprocal of intensity of scattered light 
(bottom) as a function of temperature of deoxygenated HbA at 33.3g/dl. The spinodal 
temperature TS was determined from extrapolation of I-1 from light scattering. Dashed 
line shows fitting curve of I-1. The same curve is also shown in intensity space. 
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Figure 4.16. Intensity of scattered light (top) and reciprocal of intensity of scattered light 
(bottom) as a function of temperature of HbSCO at 32.2g/dl. The spinodal temperature TS 
was determined from extrapolation of I-1 from light scattering. Dashed line shows fitting 
curve of I-1. The same curve is also shown in intensity space. 
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Figure 4.17. Intensity of scattered light (top) and reciprocal of intensity of scattered light 
(bottom) as a function of temperature of deoxygenated HbS at 16.8 g/dl. The spinodal 
temperature TS was determined from extrapolation of I-1 from light scattering. Dashed 
line shows fitting curve of I-1. The same curve is also shown in intensity space. 
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Figure 4.18. Intensity of scattered light (top) and reciprocal of intensity of scattered light 
(bottom) as function of temperature of deoxygenated cross-linked HbA at 14.1 g/dl. The 
spinodal temperature TS was determined from extrapolation of I-1 from light scattering. 
Dashed line shows fitting curve of I-1. The same curve is also shown in intensity space. 
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Chapter V: Liquid-Liquid Demixing (LLD)  
 
Liquid-liquid Demixing Phase Transition 
 The intensity of scattered light of the hemoglobin sample remains approximately 
constant when the temperature of the sample is lower than a certain value, and the 
intensity keeps increasing after the temperature of the sample exceeds that value. This 
fact brings a lot of curiosity. One explanation (San Biagi and Palma 1991; Vaiana et al., 
2003, 2005; Manno et al., 2004) is that the increased part of intensity of scattered light 
results from a liquid-liquid demixing (LLD) phase separation of the hemoglobin solution. 
In LLD, the solution can spontaneously go from a homogeneous liquid state to a non-
homogeneous (demixed) state that has two sets of regions of higher and lower 
concentration, with respect to the average concentration of the solution, as long as a 
certain thermodynamic condition is satisfied. The solution’s tendency to demix changes 
with the thermodynamic condition. There is a critical divergence of amplitude, coherence 
length of anomalous concentration fluctuations occurring when the spinodal temperature 
TSp, which represents the temperature of thermodynamic instability, is approached 
(Kadanoff 1976; Stanley 1971; Cahn 1965; de Gennes 1979). Figure 5.1 shows the 
concept of liquid-liquid demixing. 
 The LLD concept is often used in studying thermodynamics of proteins solution, 
such as hemoglobin (San Biagio and Palma 1991; Bulone et al., 1993; Vaiana et al., 2003, 
2005; Manno et al., 2004; Galkin et al., 2002; Chen et al., 2004), bovine serum albumin 
(San Biagio 1996), γ crystalline proteins in the eye lens (Liu et al., 1995, 1996; Benedek  
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Figure 5.1. The sketch of homogenous solution, demixed state, and polymer. Solution 
that is a uniform distribution is more like in a gas phase. In demixed state, which is still in 
liquid phase, the contacts between two molecules are random.  The molecules in polymer 
are organized and therefore a polymer is more like in solid phase.  
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et al., 1999; Annunziata et al., 2002, 2003; Thurston 2006; Wang and Annunziata 2007). 
The theory behind the LLD is more often used in describing the ferromagnetic transition 
or the antiferromagnetic transition, in which the order parameter is the local 
magnetization or the local staggered magnetization rather than the local concentration in 
LLD (Kadanoff 1976; Stanley 1971).  
 LLD of proteins and protein association are well distinct from each other. 
Demixing is a liquid-liquid phase transition whose thermodynamic is quite different with 
that of protein association.  Proteins association will lead to polymer that has long range 
order, and LLD will lead to protein solution with two sets of regions of lower liquid 
phase and higher liquid phase without long range order.  
 
Flory-Huggins Mean Field Theory 
 The thermodynamics of the LLD of binary solutions of polymers (in our case 
proteins) and solvent is able to be explained in a simplified lattice chain theory called 
Flory-Huggins mean field theory. The Flory-Huggins mean field theory uses a lattice to 
arrange the polymer chains and solvents (Teraoka 2002) and compares the free energy of 
the polymer-solvent system before mixing and the free energy after mixing. Consider a 
solution containing NS solvent molecules and NP polymer chains consisting of N 
monomers. The solution is divided into L sites. Each of the NS solvent molecules can 
occupy a site and each of the monomer of the NP polymer chains can also only occupy a 
site. After all the monomers of the polymer chains are put into the empty sites one by one, 
the rest of the empty sites are filled with the NS solvent molecules, which gives 
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L=NS+N·NP. If we assume that the monomer of polymer and the solvent molecule 
occupies the same volume, the volume fraction of the polymer chains φ is given by: 
                 LNN P=φ                                                               (5.1) 
and the number of solvent molecules NS is related to φ by: 
                              LNS )1( φ−=                                                             (5.2) 
The Flory-Huggins mean field theory only accounts the interactions between nearest 
neighbors. Consider two monomers of polymer mixing with two solvent molecules. 
     PP + SS → 2PS                                                          (5.3) 
here, P stands for a monomer of polymer, and S is a solvent molecule. Note that the 
direction of the arrow refers to mixing and the direction is from right to left in demixing 
process.  Denote the interaction energy between two monomers of polymer by uPP, the 
interaction energy between monomer in polymer and solvent molecule by uPS, the 
interaction energy between two solvent monomers by uSS. Here, all of the interactions are 
expressed on average, and the microscopic details of polymer are not accounted. Mixing 
two monomers of polymer with two solvent molecules brings the change in internal 
energy 2uPS−(uPP+uSS). The change in internal energy Δu due to the formation of one P-S 
contact is given by: 
2/)( SSPPPS uuuu +−=Δ                                                 (5.4) 
The Flory-Huggins χ parameter is defined as: 
             kTuuuZkTuZ SSPPPS /)2/)((/ +−=Δ=χ                                (5.5) 
here Z is the lattice coordinate, k is Boltzmann’s constant and T is absolute temperature 
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of solution. By its definition, a positive χ means that contacts between two monomers in 
polymer (P-P) and contacts between two solvent molecules (S-S) are energy favorable 
compared with contacts between polymer-solvent (P-S) contacts. Correspondingly, a 
negative χ means that polymer dissolution is energy favorable. Since all of the 
interactions, uSS, uPS, and uPP are averages, χ is assumed to be independent of the polymer 
solution composition. The change in internal energy on mixing ΔUmix is represented by: 
           ( ) )1(2/)()1( φφφφ −+−=−Δ=Δ SSPPPSmix uuuZLuZLU                        (5.6) 
If the volume change on the mixing is neglected, Δu can be equated to the change in 
enthalpy ΔH due to the formation of one P-S contact. This is generalized to the change in 
free energy below. For the same reason, the change in internal energy on mixing ΔUmix 
can be equated to the change in enthalpy ΔHmix due to mixing, which gives: 
( ) )1(2/)( φφ −+−=Δ=Δ SSPPPSmixmix uuuZLUH                              (5.7) 
 The change in entropy before and after mixing is given as: 
( ))1ln(ln φφ −+−=Δ SPmix NNkS                                           (5.8) 
Combining eqn. 5.7 and 5.8 gives the total free energy of mixing: 
       ( ))1()1ln(ln φχφφ −+−+=Δ−Δ=Δ PSPmixmixmix NNNNRTSTHG            (5.9) 
The chemical potential difference ΔµP of the polymer chain between the solution and the 
polymer melt is given by calculating the derivative of ΔGmix with respect to NP, which 
gives:  
     ( )2
,,
)1()1)(1(ln φχφφµ −+−−−=⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
∂
Δ∂
=Δ NNRT
N
G
SNpTP
mix
P                (5.10) 
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The chemical potential difference ΔµS of the solvent molecule between the solution and 
the pure solvent is given as: 
 ( )2
,,
)/11()1ln( χφφφµ +++−=⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
∂
Δ∂
=Δ NRT
N
G
PNpTS
mix
S                  (5.11) 
When the concentration of polymer increases, the N solvent molecules are replaced by a 
polymer chain consisting N monomers. In that case, the change in the chemical potential 
of the solution is described as: 
   ( ))21()1ln(1ln φχφφµµµ −+−−−+=Δ−Δ≡Δ NNNRTN SP              (5.12) 
 The spinodal line, which is the boundary between the stable region and the 
unstable region, is defined by: 
         0
,
2
2
=⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
∂
Δ∂
pT
mixG
φ
                                                    (5.13) 
This gives the expression of the spinodal line: 
      02
1
11
=−
−
+ χ
φφN
                                                  (5.14) 
The instability condition is given as: 
          02
1
11
<−
−
+ χ
φφN
                                                  (5.15) 
The binodal line (or coexistence curve) denotes the condition at which two liquid phases 
in the demixed system may coexist. In other words, the binodal line separates the one-
phase region from the two-phase region. The binodal line is defined by: 
           ( ) ( ) ( ) ( )bSaSbPaP and φµφµφµφµ ==                              (5.16) 
100 
 
here, φa and φb are the volume fractions of polymer in the two coexist phases a and b, 
respectively. µP and µS are the chemical potentials of the polymer and the solvent. The 
binodal line is described by: 
 22 )1()1)(1(ln)1()1)(1(ln bbbaaa NNNN φχφφφχφφ −+−−−=−+−−−         (5.17) 
In the region above the spinodal line, the system is unstable and fluctuations of 
concentration eventually lead the solution to a dispersion of droplets of one of the 
equilibrium phases in the other one. Solution in the region between binodal line and 
spinodal line are metastable.  The region below the binodal line is stable. The spinodal 
line and the binodal line are shown in Figure 5.2. In the χ-φ plane, the critical point is the 
position at which ∂χ/∂φ=0. That gives, 
( )
21
221
1
1
2
1
N
and
N
N
CC +
=
+
= φχ                               (5.18) 
 In the original Flory-Huggins theory, χ=ZΔu/kT (from eqn. 5.5), which assumes 
that the exchange of P and S only involves energy change Δu. In real systems, the 
exchange of P and S will also cause the change of thermal vibration and rotations of both 
solvent and polymers (Kurata 1982). This effect may be treated as an entropic 
contribution Δs due to the formation of a solvent-polymer nearest pair. We may assume 
that the free energy change ΔF of the solution due to the formation of the solvent-
polymer nearest pair can be described by ΔF=ΔH-TΔs, which gives: 
))(1( sTHZLFmix Δ−Δ−=Δ φφ                                             (5.19) 
and eqn. 5.9 will become:        
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Figure 5.2. Phase diagram in temperature−concentration plane. The spinodal line is 
shown by the dashed line. The region that is above the spinodal line is the demixed 
region (yellow area), which is unstable. In the demixed region, the solution will 
spontaneously generate regions of lower and higher concentration. The binodal line is 
shown in the solid line. The region that is below the binodal line is the homogeneous 
region (cyan area), which is stable. The region (white) between the spinodal line and 
binodal line are metastable. The open circle shows the critical point. In the Flory-Huggins 
mean field theory, both spinodal line and binodal line are symmetric. The direction of 
arrow shows the direction demixing process. While approaching spinodal temperature, 
the amplitude and lifetime of concentration fluctuations diverge critically, which are 
predicted by phase transition theory (Kadanoff 1976; Stanley 1971; Cahn 1965; de 
Gennes 1979).   
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( ))1()1ln(ln φχφφ −+−+=Δ−Δ=Δ PSPmixmixmix NNNNRTSTFG
       
    (5.20) 
and all of the other equations will remain the same as long as the Flory-Huggins χ 
parameter is redefined as: 
        kTZSTH /)( Δ−Δ=χ                                                 (5.21) 
 All of the above equations can also be used in the case of proteins solution as long 
as a proper value for N is chosen, for example, N=1 when proteins are globular proteins, 
such as hemoglobin monomers. 
 Substituting eqn. 5.21 into eqn. 5.14 gives the expression of spinodal temperature 
TSp for hemoglobin: 
   
1
)1(2
−
⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
−
+ΔΔ=
φφ
RSHTSp                                              (5.22) 
here, R indicates the gas constant. Fitting the spinodal curve with this expression allows 
determining ΔH and ΔS.  
 
Light Scattering in Liquid-Liquid Demixing 
 When the spinodal temperature TSp is approached, the amplitude 〈(Δc)2〉 of 
concentration fluctuation and the fluctuation correlation length ξ is related to the reduced 
temperature ε≡(T-TSp)/TSp (Kadanoff 1976; Stanley 1971; de Gennes 1979).  
       ( )
∗
−
∝
−
∝Δ
γγ
ξ
Sp
Sp
Sp
Sp
T
TT
and
T
TT
c 2                         (5.23) 
Here Δc is the concentration fluctuation and 〈(Δc)2〉 is average of (Δc)2. In the mean field 
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approximation, γ =−1 and γ∗=−1/2 (Kadanoff 1976; Stanley 1971; Scholte 1972).  
 In static light scattering experiments, the intensity of scattered light IS is 
proportional to the average of square of concentration fluctuation (from eqn 2.7) in the 
sample: 
   ( )2cIS Δ∝                                                            (5.24) 
The fluctuation correlation length ξ is related to the diffusion constant in the so-called 
hydrodynamic approximation (Kawasaki 1970) by: 
                                 DkT πηξ 6/=                                                          (5.25) 
Here k is Boltzmann constant, T is the absolute temperature of solution, η is the viscosity 
of  solution, and D is the diffusion constant. ξ is similar to the hydrodynamic radius RH of 
the scattering particle in solution (from eqn 2.28): 
                  DkTRH πη6/=                                                         (5.26) 
And D can be obtained by getting the relaxation time τq=(q2D)-1 (from eqn. 2.27) in 
dynamic light scattering experiment.  
 Combining eqn. 5.24 with eqn. 5.25, we have 
Sp
Sp
Sp
Sp
S T
TT
and
T
TT
I
−
∝
−
∝− 21 ξ                                  (5.27) 
The spinodal temperature TSp can be obtained by extrapolating to zero of 1−SI and ξ
2 in the 
region of thermodynamic stability at given concentration (Scholte 1972, San Biagio and 
Palma 1991; San Biagio et al., 1996; Bulone et al., 1993; Manno et al., 2001; Vaiana et 
al., 2003, 2005).  
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Static Light Scattering Data of Hemoglobin Solution Analyzed By Using LLD 
Theory   
 The spinodal temperatures of different hemoglobin derivatives are shown in 
Figure 5.3 and 5.4. The spinodal temperatures of deoxygenated HbS, deoxygenated HbA, 
and HbSCO measured in the present work show good agreements with the data obtained 
in San Biagio’s work (San Biagio et al., 1991) and Vaiana’s work (Vaiana et al., 2005), 
respectively. The values of ΔH and ΔS were also obtained by fitting the spinodal 
temperatures of hemoglobin derivatives in eqn. 5.22. The error bars were used to weight 
the fitting. One percent of the values were set as error for the spinodal temperatures 
obtained from previous works (San Biagio et al., 1991; Vaiana et al., 2005) because of 
lack of information about error bars there. The results are shown in Table 5.1. In order to 
compare our data with data obtained in previous works (San Biagio et al., 1991; Vaiana 
et al., 2005), the fitting was performed by two different ways. a) All of the spinodal 
temperature data that were obtained in both previous work and present work were used in 
fitting. b) Only the spinodal temperature data that were obtained in present work were 
used in fitting. The values of ΔH and ΔS that were obtained in different way agreed with 
each other well.   
 The TSp, ΔH and ΔS that was obtained in the previous works (San Biagio et al., 
1991; Vaiana et al., 2005) and in the present work was the same within error, which 
proved the design of our apparatus successful. With the help from the new data, results 
also show that there is a clear divergence between the spinodal temperatures of 
deoxygenated HbS and those of HbSCO after concentration passes the solubility but  
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Figure 5.3. Spinodal temperatures of HbA. Squares indicate the spinodal temperatures of 
deoxygenated HbA measured by San Biagio (San Biagio et al., 1991). All the other data 
were obtained in the present work. The spinodal temperatures of deoxygenated HbA are 
shown in filled squares; the spinodal temperatures of HbACO (open circles); the spinodal 
temperatures of deoxygenated cross-linked HbA (diamonds). The solid line indicates the 
fitting curve of the Flory-Huggins theory for spinodal temperatures of deoxygenated HbA, 
which is generated by using all of the data obtained in both the previous work (San 
Biagio et al., 1991) and the present work. 
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Figure 5.4. Spinodal temperatures of HbS. Please be aware of that the scale is changed 
comparing with Figure 5.3. Open circles indicate the spinodal temperatures of 
deoxygenated HbS measured by San Biagio (San Biagio et al., 1991). Open squares 
represent the spinodal temperatures of HbSCO measured by Vaiana (Vaiana et al., 2005). 
All the other data were obtained in the present work. The spinodal temperatures of 
deoxygenated HbS are shown in filled circles; the spinodal temperatures of HbSCO 
(filled squares). The dashed line indicates the solubility at 36.5°C. The solid line 
indicates the fitting curve of the Flory-Huggins theory for spinodal temperatures of 
deoxygenated HbS. All of the data obtained in both the previous work (San Biagio et al., 
1991) and the present work were used in fitting. The dotted line indicates the fitting curve 
of the Flory-Huggins theory for spinodal temperatures of HbSCO, which is generated by 
using all of the data obtained in both the previous work (Vaiana et al., 2005) and the 
present work. 
  
107 
 
 
 
 
Table 5.1 Values of ΔH and ΔS parameters related to LLD 
 ΔH (kcal/mol) ΔS (cal/K mol) 
Deoxygenated HbA1 −7.5 −27.5 
Deoxygenated HbA2 −7.5±2.1 −27.9±5.2 
Deoxygenated HbS1 −15.6 −57.6 
Deoxygenated HbS2 −15.0±2.8 −55.1±8.0 
Deoxygenated HbS3 −16.0±4.3 −58.3±12.7 
HbSCO4 −22.3 −75.1 
HbSCO2 −23.0±3.4 −76.4±9.8 
1. Opposite signs were taken in San Biagio and Palma (San Biagio and Palma 1991). 
2. Values are obtained by fitting all of the spinodal temperatures in San Biagio’s work 
and present work. 
3. Values are gained by fitting the spinodal temperatures only obtained in present work. 
4. Values are taken in Vaiana’s work (Vaiana et al., 2005). 
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divergence does not exist between the spinodal temperatures of deoxygenated HbA and 
those of HbACO.  
 In fact, the demixed region has never been reached in the light scattering 
experiments determining the spinodal temperature of hemoglobin that have been done in  
previous works (San Biagio et al., 1991; Vaiana et al., 2005) or the present work. All the 
scattered intensity data were taken while approaching the demixed region. The reason is 
that the spinodal temperatures of non-polymerized hemoglobin are too far above 
physiological condition to reach and the spinodal temperatures of deoxygenated 
hemoglobin are lower than the former but still above the solubility. Since they are above 
solubility, the system will form polymers prior to demixing. The solubility curve and the 
spinodal curve of deoxygenated HbS are shown in Figure 5.5. 
 Aggregation occurs while approaching the demixed region. Vaiana et al., studied 
aggregation in the same work determining the spinodal temperatures of HbSCO (Vaiana 
et al., 2005). After the temperature of the sample was raised from 10°C to 45°C in 10°C 
or 5°C intervals, the temperature of sample was brought back to 10°C for 30 minutes. 
Their results show that no substantial increases in hydrodynamic radius RH were 
observed below 35°C but there were increase of the average of RH after the temperature 
of sample was brought back to 10°C if the temperature was raised to 40°C and 45°C 
previously. Compared with the original value of RH~40Å, the RH was approximate 45Å 
or 65Å if the temperature was raised to 40°C or 45°C, respectively. It was also verified 
that there was no denaturation happening during this process (Vaiana et al., 2005). 
According to light scattering theory, the intensity of scattered light IS is proportional to 
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M2c (from eqn. 2.15, here M stands for molar mass of aggregate and c is number 
concentration of aggregate), which means IS is proportional to R6c if aggregates have 
same density. Base on that, the intensity of scattered light from aggregate with RH~45Å is 
twice as that from aggregate with RH~40Å, and the intensity of scattered light from 
aggregate with RH~65Å is 18 times as that from aggregate with RH~40Å if their 
concentration are same. Since most of increase in IS obtained in the experiments is less 
than 60% of initial IS, is it possible that the increase is not due to liquid-liquid demixing 
but aggregation? 
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Figure 5.5. The spinodal curve and solubility curve of deoxygenated HbS. The spinodal 
curve (the dashed lines) is obtained by fitting the spinodal temperatures measured in San 
Biagio’s work (San Biagio et al., 1991) and the present work. Fitting expression uses 
eqn.5.22. The solubility curve (the solid line) is fitting from solubility data (Ross et al., 
1977). 
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Chapter VI: Small Aggregates in Hemoglobin Solution 
 
Light scattered from monomers and dimers 
 If the scattered light that we observed in the light scattering experiment results 
from aggregates in hemoglobin solution rather than LLD, is it possible to have an 
increasing intensity when the temperature of the sample exceed a certain value?  
 We start at the simplest model which assumes that there are only monomers and 
dimers in the solution. At low temperature, the solution consists of monomers and the 
concentration of dimers is negligible. More and more dimers are formed as the 
temperature of the hemoglobin solution increases and consequently the intensity of light 
scattered by dimers increases. If the temperature of the solution keeps increasing, 
eventually at a certain temperature, the concentration of dimers reaches a high enough 
value at which the intensity of scattered light due to the formation of dimers becomes 
detectable.  
 The change in the free energy due to the formation of an aggregate is denoted as: 
     STHG Δ−Δ=Δ                                                       (6.1) 
Here, ΔH represents the change in enthalpy due to the formation, ΔS is the change in the 
entropy due to the formation, and T is the absolute temperature of solution. The number 
concentration of dimers c2 is described by: 
        ( ) RSRTHRTSTH eeec ///2 ~
ΔΔ−Δ−Δ− =                                      (6.2) 
where, R is the gas constant. Since the intensity of scattered light only increases when the 
temperatures of solution are in a range that is relatively small value compared with the 
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absolute temperature of solution T, we can describe T as T=T0+δT, which gives: 
     ( ) ( ) ( ) ( ) ( ) TTHTHTTTHTTTHTH eeeee δδδ
2
000
1
0
1
0
1
0 ///1/1/ Δ−Δ−Δ+ΔΔ ==≅
−−−
     (6.3) 
Substituting eqn. 6.3 into eqn. 6.2 gives: 
( ) TRTHRSRTH eec δ
2
00 ///
2 ~
ΔΔ+Δ−                                          (6.4) 
The eqn. 6.4 shows that the concentration of dimers can be expressed as an exponential 
function of temperature. According to light scattering theory, the intensity of scattered 
light IS is proportional to M2c (from eqn. 2.15, here M stands for the molar mass of 
aggregate and c is the number concentration of aggregate), which gives: 
 ( ) TRTHRSRTHS eeMcMI
δ200 ///2
2
2 ~~ ΔΔ+Δ−                                   (6.5) 
In chapter IV, we showed the intensity of scattered light being fitted by a function of 
temperature with form IS=a·exp(bT)+c. Here, a, b, c are fitting parameters and T is the 
temperature of the solution in Celsius.  From eqn. 6.5, the value of b is given as: 
 20/ RTHb Δ=                                                          (6.6) 
The good agreement between the fitting curves and the experimental data suggests that 
the assumption about the intensity of scattered light due to the formation of aggregates is 
reasonable.  The values of the fitting parameter b as a function of concentrations of all the 
hemoglobin derivatives measured in the present work are shown in Figure 6.1-6.3. We fit 
b as a linear function of concentration for different hemoglobin derivatives respectively. 
Because the slopes of the linear functions are zero within error, this suggests that b is 
independent of the concentration. The error weighted average of b for each hemoglobin 
derivative rather than a linear fitting curve is shown in Figure 6.1-6.3.  
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Figure 6.1.  The parameter b of fitting curve of scattered intensity of deoxygenated HbS 
and HbSCO. The vaules of b are shown in filled circles. The error weighted average of b 
is shown by the dashed line. The linear fitting of b for deoxygenated HbS, which is not 
shown in the graph, is b=0.083(±0.079) + 0.004(±0.005)×concentration. The linear fitting 
of b for HbSCO, which is also not shown in the graph, is b=0.249 + 0.003×concentration. 
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Figure 6.2.  The parameter b of fitting curve of scattered intensity of deoxygenated HbA 
and HbACO. The values of b are shown in filled circles. The error weighted average of b 
is shown by the dashed line. The linear fitting of b for deoxygenated HbA, which is not 
shown in the graph, is b=0.43(±0.45) − 0.007(±0.014)×concentration. The linear fitting of 
b for HbACO, which is also not shown in the graph, is b=0.21−0.002×concentration. 
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Figure 6.3.  The parameter b of fitting curve of scattered intensity of deoxygenated cross-
linked HbA. The vaules of b are shown in filled circles. The error weighted average of b 
is shown by the dashed line. The linear fitting of b for deoxygenated cross-linked HbA, 
which is not shown in the graph, is b=0.469−0.012×concentration.  
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 The values of ΔH for hemoglobin derivatives can be obtained by substituting the 
value of b into eqn.6.6. Since the intensity data that was used in the fitting was taken at 
temperature in a range 5°C to 40°C, we take the average value 22.5°C as the value of T0 
in the eqn. 6.6 to calculate ΔH. The values of ΔH for five hemoglobin derivatives are 
shown in Table 6.1. 
 
The determination of thermodynamic equilibrium association constant  
 For association, considering protein monomer with molar mass M1 that may 
reversibly associate to form two or more aggregates, the thermodynamic equilibrium 
association constant is given by: 
   ( )i
ii
i c
cK
11γ
γ
≡                                                        (6.7) 
here, Ki is the equilibrium association constant, ci indicates the concentration of ith mer, γi 
stands for the activity coefficient of ith mer at concentration ci, γ1 stands for the activity 
coefficient of monomer at concentration c1. Based on light scattering theory, the Rayleigh 
ratio Rʹ′ of a solution with multiple components can be described as (from eqn. 2.12): 
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here, IS denotes the intensity of scattered light, I0 is the intensity of incident light, r is the 
distance between sample and detector, V is the scattering volume, b is the total species 
number, ci is the molar concentration of the ith species, µj is the chemical potential of jth 
component, NA is the Avogadro’s number, λ is the wavelength of incident light in the  
117 
 
 
 
Table 6.1 The ΔH and ΔS of hemoglobin derivatives in monomer and dimer model. 
 Deoxygenated HbS 
Deoxygenated 
HbA 
Deoxygenated 
 XLA HbACO HbSCO 
ΔH (kcal/mol) 11.7±5.8 19.4±11.2 19.4±11.2 14.8±11.0 28.4±8.6 
ΔH∗ (kcal/mol) 11.7±5.8 19.4±11.2 19.4±11.2 14.8±11.0 28.4±8.6 
ΔS(cal·mol-1·K-1) -36.4±1 -58.5±1.4 -57.6±1.5 -42.8±0.4 -80.5±2.4 
ΔH∗ is the enthalpy change per molecule. 
ΔH is the enthalpy change per contact. 
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solution, R is the gas constant, n is the refractive index, T is the absolute temperature of 
solution, w is the w/v concentration of species, Mi and Mj is the molar mass of ith and jth 
species, respectively. For aggregates, Mi=iM1. The chemical potential of ith component 
can be described as: 
         iiii cRT γµµ ln
0 +=                                                  (6.9) 
here γi denotes the thermodynamic activity coefficient of the ith species. 
 In the case of two scattering species in solution, eqn. 6.8 becomes (from eqn. 
A.1.34-37 and A.1.26): 
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where, c1 and c2 is the molar concentration of the first and second scattering species, 
respectively.  Δc1 and Δc2 is the fluctuation of the molar concentration of the first and 
second scattering species, respectively. If the two species are indexed by i and j, we have: 
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here ρi, and wi denote the number density and the w/v concentration of the ith species, 
respectively. The activity coefficient γ for the ith species in a solution mixture is given by 
(Boublík, 1974; Minton 2007); 
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Here, iii rhH = , 
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iρ1 . Hi represents an 
effective radius of the ith species of particle (Kihara, 1953), Si denotes the surface area of 
the ith species of particle, and Vi denotes the volume of ith species of particle (Minton, 
2007). If one assumes that all species are represented by identically shaped particles, hi = 
h, si = s, and vi = v. It gives: 
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In the case of spherical particles, h = 1, s = 4π, and v = 4π/3. 
j
i
c∂
∂ γln  is given by (from 
eqn. A.1.28-32): 
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Here, Q ≡ 1− 〈V〉. The value of radius ri of sphere can be estimated by (Minton 2007): 
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Where NA is Avogadro’s number, veq is the specific volume of particle, for hemoglobin 
veq = 0.77 cm3/g.  
 If IS denotes the value of the intensity of scattered light after intensity increase 
and Ib denotes the value of the intensity of scattered light before it increases, the 
concentration of dimer can be calculated by using eqn. 6.10. with assumption that the 
difference between IS and Ib results from the formation of dimer. In order to exclude the 
uncertainty caused by measuring scattered volume, we assumed that Ib is due to monomer 
only. Under this assumption, we have: 
Rʹ′12/Rʹ′1=IS/Ib                                                        (6.22) 
Here, Rʹ′1 denotes the Rayleigh ratio of pure monomer solution and Rʹ′12 denotes the 
Rayleigh ratio of solution containing monomer and dimer. The expression of Rʹ′12/Rʹ′1 in 
terms of c1 and c2 can be obtained from eqn. 6.10-21.  
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Figure 6.4 shows a comparison of the experimentally measured intensity Ib and 
theoretically predicted intensity A·Rʹ′1 with various concentration. Rʹ′1 is calculated by 
using eqn. 6.10 with pure monomers in the solution, and A is a factor which is 
proportional to the intensity of incident light, scattering volume, and reciprocal of the 
square of distance between the sample and the detector. We get the value of A by using 
least squares fitting: 
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Figure 6.4. A comparison of the experimentally measured intensity and theoretically 
predicted intensity.  
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Here, Ibi represents the value of Ib from ith sample, Rʹ′1i indicates the value of Rayleigh 
ratio from pure monomer solution at ith sample’s concentration. Figure 6.4 shows that the 
trend of Ib as a function of concentration of solution is consistent with the Rayleigh ratio 
of pure monomer solution, which suggests that it is reasonable to assume that the flat part 
of intensity of scattered light Ib is due to monomers in solution. 
 For aggregation, the total mass of the aggregates ctot is conserved. 
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Here, L stands for the number of scattering species, Ki is the equilibrium association 
constant, and ctot is equal to the concentration of sample. The concentration of dimer will 
be obtained by solving eqn. 6.23 and eqn. 6.25. Since the intensity of scattered light is a 
function of temperature at a given concentration, the relation between the equilibrium 
association constant of formation of dimer K2 and the temperature is finally obtained. The 
equilibrium association constants of formation of dimer in HbA solution with various 
temperatures are shown in Figure 6.5. In order to calculate K2, the values of γ2, c2, γ1 and 
c1 that were obtained by analyzing experimental data were substituted into eqn. 6.7. 
However, K2 shows some concentration dependence when we chose the radius of dimers 
r2=21/3r1, where r1 is the radius of monomers. Since both ji c∂∂ γln and γi are related to ri, 
and the Rayleigh ratio is related to ji c∂∂ γln , the value of K2 will vary with ri. We found 
that the concentration dependence of K2 almost disappeared if we let r2=1.61/3r1. 
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Although defining r2=1.61/3r1 means that the volume of dimer is 1.6 times as the volume 
of monomer, it is possible because hemoglobin monomer is not a perfect sphere and the 
distance between the contact surfaces of dimer and the center of mass of each monomer 
might be smaller than the radius of monomer r1 when the monomer is treated as a sphere.  
 The K2 for all of the hemoglobin derivatives are shown in Figure 6.6. In Figure 
6.6, the values of K2 for all of the hemoglobin derivatives are separated into two groups. 
One group consists of only deoxygenated HbS and the other one contains all the other 
non-polymerizing hemoglobin derivatives. The deoxygenated HbS has larger K2 than all 
the other non-polymerizing hemoglobin derivatives, which might suggest that 
deoxygenated HbS is able to grow more dimers or bigger aggregates than all the other 
non-polymerizing hemoglobin derivatives do.  
 The thermodynamic equilibrium association constant of the dimer K2 can be 
given as: 
                 STHKRT Δ−Δ=− 2ln                                               (6.26) 
Eqn. 6.26 shows that if the RTlnK2 data is fitted as a linear function of temperature T 
with form RTlnK2=A+B×T, the value of -ΔH will be the intercept A and the slope gives 
ΔS. Since the values of ΔH have been obtained by using eqn. 6.6, if the RTlnK2 data is 
extrapolated from the temperature where the intensity of scattered light starts to increase 
to 0K, the intercept A should be equal to -ΔH and the slope gives the ΔS. The reason that 
we choose this extrapolation method instead of fitting the RTlnK2 data with a linear 
function of temperature is that the value of RTlnK2 is not a perfect linear function of 
temperature in the case of deoxygenated HbS samples. Actually, the value of RTlnK2  
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Figure 6.5. The equilibrium association constants of formation of dimer in HbA and 
HbSCO samples. 
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Figure 6.5 (continued). 
The values of RTlnK2 of the samples for 11.4g/dl deoxygenated HbA (the open 
diamonds), 28.3g/dl deoxygenated HbA (the up triangles), 33.3g/dl deoxygenated HbA 
(the open circles), 14.1g/dl deoxygenated XLA (the open stars), 29.0g/dl deoxygenated 
XLA (the filled stars), 15.7g/dl HbACO (the down triangles), 33.4g/dl HbACO (the filled 
circles), 15.9g/dl HbSCO (the solid line) and 32.2g/dl HbSCO (the dashed line) when 
r2=21/3r1 (top) and r2=1.61/3r1 (bottom). K2 stands for the equilibrium association constant 
of formation of dimer, R is the gas constant, T is the temperature of sample, r2 is the 
radius of hemoglobin dimer and r1 is the radius of hemoglobin monomer. 
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Figure 6.6. The equilibrium association constants of formation of dimer for all of the 
hemoglobin derivatives. The data of deoxygenated HbS are shown in the red color. The 
concentration of deoxygenated HbS are 7.7g/dl (half filled circles), 8.4g/dl (half filled up 
triangles), 11.2g/dl (half filled down triangles), 14.7g/dl (half filled diamonds), 15.7g/dl 
(half filled left triangles), 16.8g/dl (filled circles), 17.4g/dl (filled up triangles), 17.8g/dl 
(open circles), 19.5g/dl (filled down triangles), 19.7g/dl (open up triangles), 20.2g/dl 
(filled diamonds), 20.8g/dl (open down triangles), 22.7g/dl (filled left triangles), 23.6g/dl 
(filled right triangles), 26.9g/dl (filled stars). The data of deoxygenated cross-linked HbA 
are shown in the pink color, 14.1g/dl sample (filled circles), 29.0g/dl (filled up triangles). 
The data of HbACO are shown in cyan color, 15.7g/dl sample (open up triangles), 
33.4g/dl (open circles). The data of deoxygenated HbA are shown in the blue color, 
11.4g/dl sample (filled up triangles), 28.3g/dl (filled down triangles), 33.3g/dl (filled 
circles). The data of HbSCO is shown in the dark yellow color, 15.9g/dl (filled circles). 
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Figure 6.7. The ΔS of hemoglobin derivatives in the monomer and dimer model. The ΔS 
of deoxygenated HbS (solid circles), HbACO (open up triangles), deoxygenated cross-
linked HbA (open left triangles), deoxygenated HbA (filled up triangles), HbSCO (open 
circles).  
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shows curvature at higher temperature in Figure 6.6. We will discuss the possible reasons 
of this curvature later. The values of ΔS for hemoglobin derivatives obtained in the 
extrapolation are shown in Figure 6.7, the averages of ΔS are shown in Table 6.1. 
 
Light scattered from monomers and oligomers 
 After we obtained the values of K2 for deoxygenated HbS by using the monomers 
and dimers model, we found that the concentration of dimer c2 show a strange relation 
with the concentration of monomer c1. As shown in Figure 6.8, c2 increase while c1 
decreases. Since in order to get this K2, we assumed that the increased intensity of 
scattered light is due to the formation of dimers only, this strange relation suggests that 
oligomers exist in the deoxygenated HbS solution.  
 In order to figure out the size of oligomer in a simple way, we assumed that there 
are only two species in the solution, monomer and another oligomer with size i. From eqn. 
6.10, since the Rayleigh ratio Rʹ′ has,  
jj cMR
2~'                                                                (6.27) 
here cj is the concentration of j-mer in the solution and Mj is the molar mass of j-mer, 
which makes the value of ci related to the value of c2 obtained when we assume only 
monomer and dimer in the solution, we can determine the size of i by using the following 
procedure. We drew a graph showing log10(c2) VS log10(c0) for the deoxygenated HbS 
samples with various concentrations. Here c2 is the concentration of dimer at 20°C and c0 
is initial concentration. If there were no c2 data at 20°C for some deoxygenated HbS 
samples, the values of log10(c2) at 20°C were obtained by extrapolating the values of 
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log10(c2) at temperatures we reached. We didn’t use the log10(c2) data from all of the 
deoxygenated HbS samples to draw the graph but chose the data from the samples at 
concentrations (14.7 g/dl, 15.7 g/dl, 16.8 g/dl, 17.4 g/dl, 19.5 g/dl, and 19.7 g/dl) at which 
the exponential fitting curves have the best match with the intensities of scattered light 
that are shown in Figures 4.1-4.8. As shown in Figures 4.1-4.8 and Table 4.1, the 
exponential fitting parameters have relatively large error bars because of the lack of 
intensities data in a wide temperature range. Deoxygenated HbS at high concentrations 
(>20g/dl) have low solubility temperatures that makes intensities be taken in a narrow 
temperature range. Using those data with large uncertainty in the exponential fitting 
parameters will make the oligomer size estimation difficult because the uncertainty in the 
exponential fitting will transfer to the oligomer size estimation. We got the slope S1 by 
fitting log10(c2) as a linear function of log10(c0). We kept searching the sizes of aggregates 
until we found a particular i, which gives 
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Here, c0ʹ′ and c0ʹ′ʹ′ are any two initial concentrations used in the curve fitting of log10(c2) 
VS log10(c0), γ0ʹ′ and γ0ʹ′ʹ′ are the activity coefficients for hemoglobin monomer with 
concentration c0ʹ′ and c0ʹ′ʹ′, respectively.  γiʹ′ and γiʹ′ʹ′ are the activity coefficients for 
hemoglobin aggregate with size i when the initial concentration of monomer are c0ʹ′ and 
c0ʹ′ʹ′, respectively.  Once we got the value of i, we calculated the ci by assuming that the 
intensity of scattered light due to monomers and the aggregates with this particular size i, 
and got the slope S2 of linear fitting of the curve log10(ci) VS log10(c1) by using the 
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procedure mentioned above, here, c1 is not the initial concentration but the concentration 
of monomers in the solution at 20°C. We kept searching until we found a value of i that 
gave: 
 ( ) ( ) 2
11
1111
)''ln()'ln(
'')''''(ln')''(ln S
cc
cc i
i
i
i
=
−
− γγγγ                              (6.29) 
We found that the most consistent size of oligomer is 13. The same procedure was also 
used in other hemoglobin derivatives (HbSCO, deoxygenated HbA, HbACO and 
deoxygenated cross-linked HbA), and we found the size of aggregate is 4. We started 
oligomer size estimation from fitting log10(c2) VS log10(c0) rather than log10(c2) VS 
log10(c1) at the beginning because the former one is ill. As shown in Figure 6.8, c2 
increase while c1 decrease. In this process, we used another expression of γi (Ferrone et. 
Al., 1985b) instead of the one was described in eqn. 6.15. that would make this oligomer 
size estimation more complicated. The expression of γi we used is: 
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here, V (=0.77 cm3/g ) stands for specific volume of hemoglobin, c is the concentration 
of monomer in units g/cm3, and ρ (=0.55) is the ratio of the polymer density (=0.69 g/cm3; 
Sunshine et. al., 1979b) to that of the unaggregated monomer (1.26 g/cm3). The 
concentration of monomer c1, 13-mer c13 and initial concentration c0 of deoxygenated 
HbS at 20°C in the monomer and 13-mer model are shown in Figure 6.9. The RTlnK13 
are shown in Figure 6.10. As shown in Figure 6.9, the concentration of 13-mer c13 
increases while the concentration of monomer c1 increases and the curvature of the data 
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also becomes much smaller.  We get the values of ΔS for all the hemoglobin derivatives 
by using the same procedure used in the monomer and dimer model. The average 
contacts number per molecule is 2.79 in 13-mer (Ginnel 1961; Ferrone et al., 1985b) and 
0.75 in tetramer since this tetramer is linear tetramer, and the average contacts number is 
36.3 in 13-mer and 3 in tetramer. We divided ΔH that was obtained from intensity fitting 
parameter b by the contact number of oligomer (36.3 in deoxygenated HbS and 4 in other 
hemoglobin derivatives) and obtained the ΔH per contact in the formation of oligomers. 
We divided ΔS by the number of oligomer rather than the contact number, and obtained 
the ΔS per monomer in the formation of oligomers. The values of ΔH and ΔS are shown 
in Table 6.2. The ΔS per monomer in the formation of oligomers for hemoglobin 
derivatives is shown in Figure 6.11.  
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Figure 6.8. The concentration of monomer c1, dimer c2 and initial concentration c0 of 
deoxygenated HbS at 20°C in the monomer and dimer model. The solid line is a fitting 
curve with log10(c2) = −6.92(±1.47) +14.48(±3.43)×log10(c0). 
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Figure 6.9. The concentration of monomer c1, 13-mer c13 and initial concentration c0 of 
deoxygenated HbS at 20°C in the monomer and 13-mer model. The solid lines are fitting 
curves with log10(c13) = −8.77(±1.46)+14.32(±3.41)×log10(c0) (the top one), log10(c13) = 
−9.90(±1.92)+17.41(±4.60)×log10(c1) (the bottom one). 
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Figure 6.10.  The RTlnK13 of deoxygenated HbS in monomer and 13-mer model. The 
concentration of samples are 14.7 g/dl (filled circles), 15.7 g/dl (open circles), 16.8 g/dl 
(open up triangles), 17.4 g/dl (filled up triangles), 19.5 g/dl (open down triangles), and 
19.7 g/dl (filled down triangles).  
 
 
 
  
135 
 
 
 
 
Table 6.2 The ΔH and ΔS of hemoglobin derivatives in monomer and oligomer 
model. 
 Deoxygenated HbS 
Deoxygenated 
HbA 
Deoxygenated 
 XLA HbACO HbSCO 
ΔH (kcal/mol) 0.7±0.3  13.0±7.5  13.0±3.7  9.9±7.3  18.9±5.8  
ΔHʹ′ (kcal/mol) 1.8±0.9  9.7±5.6  9.7±2.8  7.4±5.5  14.2±4.3  
ΔS(cal·mol-1·K-1) -3.6±0.5  -28.2±0.4  -28.5±0.1  -20.6±0.2  -39.3±0.7  
TΔS(kcal/mol)  -1.1±0.1  -8.3±0.1  -8.4±0.1  -6.1±0.1  -11.6±0.2  
ΔGʹ′ (kcal/mol)  2.9±0.9  18.0±5.6  18.1±2.8  13.5±5.5  25.8±4.3  
 
ΔH∗ is the enthalpy change per molecule at 22.5°C. 
ΔH is the enthalpy change per contact 22.5°C. 
T=22.5°C. 
ΔGʹ′ = ΔHʹ′−TΔS at 22.5°C. 
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Figure 6.11 The ΔS per monomer of hemoglobin derivatives in the monomer and 
oligomer model. The ΔS of deoxygenated HbS (solid circles), HbACO (open up 
triangles), deoxygenated cross-linked HbA (open left triangles), deoxygenated HbA 
(filled up triangles), HbSCO (open circles).  The size of oligomer is 13 deoxygenated 
hemoglobin and 4 for other hemoglobin derivatives. 
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Chapter VII: Conclusion 
 
 We studied hemoglobin association with five hemoglobin derivatives 
(deoxygenated HbS, HbSCO, deoxygenated HbA, HbACO and deoxygenated cross-
linked HbA) by using light scattering.  We built an apparatus with a novel micro-method 
for measuring light scattering of hemoglobin solution with various temperatures. 
Compared with conventional light scattering equipments, the apparatus requires less 
amount of sample and is able to change the temperature of the sample faster. We 
observed that the intensities of scattered light keep relative constant at low temperature 
and start to increase after the temperatures of the samples exceed certain values that vary 
with concentrations of the samples and hemoglobin derivatives. The deoxygenated HbS 
scatter more light than other hemoglobin derivatives do at the same temperatures and 
concentrations. We interpreted the increase of intensity with two different theories, LLD 
and the formation of oligomers. Since both LLD and the formation of oligomers can 
explain the experimental fact that the intensity of scattered light of hemoglobin solution 
varies with temperature, we need to figure out which hemoglobin prefers.  
 
The challenges to LLD 
 Although LLD theory can explain the experimental fact that the intensity of 
scattered light of hemoglobin solution varies with the temperature, it has trouble 
explaining some other experimental facts about hemoglobin, such as the concentration 
dependence of sickle hemoglobin homogeneous nucleation rates and the concentration 
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dependence of sickle hemoglobin polymer growth rates. 
 LLD theory has trouble when it deals with the concentration dependence of sickle 
hemoglobin homogeneous nucleation rates. LLD theory states that in demixed region the 
solution will spontaneously go from a homogeneous liquid state to a non-homogeneous 
(demixed) state that has two sets of regions of higher and lower concentration, with 
respect to the average concentration of the solution. Based on LLD theory, the 
concentration dependence of the homogeneous nucleation rates should disappear in the 
demixed region. If the hemoglobin solution can be directly brought into the demixed 
region without polymerizing, hemoglobin will spontaneously go to a demixed state that 
has two sets of regions of higher and lower concentration. The hemoglobin will keep 
demixing until the free energy barrier for LLD and that of aggregation are at the same 
level.  And then, hemoglobin will make polymer in the higher concentration regions 
because the free energy of aggregation will decrease faster than that of LLD does. In 
those higher concentration regions, hemoglobin monomers will arrange their relative 
positions quickly and transfer from liquid state to solid state (polymer). Figure 7.1 shows 
the kinetics of aggregation of hemoglobin and LLD in the demixed region. The formation 
of the critical nuclei is not necessary for polymerization in the demixed region because 
polymerization start from rearrangement of hemoglobin monomers rather than the 
formation of homogenous nuclei. It means that we should expect to see that sickle 
hemoglobin homogeneous nucleation rates in demixed region do not present very high 
initial concentration dependence as it does outside of the demixed region. However, the 
experimental facts (Ferrone et al., 1985a) didn’t support it.  
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Figure 7.1.  The free energy barrier of LLD and aggregation in the demixed region. The 
free energy barrier of LLD is shown in the dashed line and the free energy barrier of 
aggregation is in the solid line. Hemoglobin will demixing first because of less energy 
cost but will grow polymers once it passes the crossing point of the two lines because the 
free energy of aggregation decrease faster than that of LLD.  
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 The product of polymer growth rate J and homogeneous nucleation rate f0 of 
sickle hemoglobin as a function of solution initial concentration was measured in the 
previous work (Ferrone et al., 1985a). Some of the data covered the demixed region. The 
polymer growth rate J can be described as: 
      −+ −= kckJ γ                                                          (7.1) 
here, γ is the activity coefficient of hemoglobin at concentration c,  
         2)1/(8ln VcVc −=γ                                                  (7.2) 
V (=0.77cm3/g) is the specific volume of hemoglobin monomer, k+ is the concentration-
independent bimolecular rate constant for addition of monomers to polymers, and k− is 
the concentration-independent bimolecular rate constant for dissociation of monomers to 
polymers. k− = γscs, cs is the solubility of hemoglobin and γs is the activity coefficient at 
solubility (Ferrone et al., 1985b). The derivative of ln(Jf0) with respect to c gives: 
 00 ln)ln()ln( fdc
dc
dc
dJf
dc
d
+= γ                                       (7.3) 
The value of dcJfd )ln( 0 can be obtained by taken the slope of log10(Jf0) VS log10(c) that 
were measured in the work (Ferrone et al., 1985a), and the value of dcJd )ln(  was 
obtained by using eqn. 7.2. At log10(c)=0.76mM, 95.11)ln( 0 =dcJfd and 
53.4)ln( =dcJd , which gives 42.7)ln( 0 =dcfd . This shows that the homogeneous 
nucleation rates still present very high initial concentration dependence in the demixed 
region in contrast to what would be expected from LLD theory.  The concentration 
dependence of Jf0 in the demixed region is shown in Figure 7.2 and Figure 7.3 shows the 
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concentrations and temperatures where the homogeneous nucleation rates were measured 
in the work of Ferrone et al. (1985a). 
 The LLD theory also has trouble explaining the concentration dependence of 
sickle hemoglobin polymer growth rates. The sickle hemoglobin polymer growth rates 
were measured in a recent work (Alexey et al., 2011). Although the purposes of that work 
were totally unrelated to LLD, an interesting result obtained in that work addressed a 
question on the LLD theory. All of the polymer growth rates that were measured in that 
work show an excellent linear fitting with the product of the initial concentrations of 
solution in the full photolysis experiments and the corresponding activity coefficients γc. 
The concentrations and the temperatures of hemoglobin solutions that were reached in 
that work are shown in Figure 7.3. The values are very close to demixed region of 
deoxygenated hemoglobin predicted by the LLD theory. Based on the LLD theory, there 
is a critical divergence of amplitude of anomalous concentration fluctuations occurring 
when the spinodal temperature is approached (chapter 5), which means that the polymer 
growth should show quite different behavior at lower temperatures and higher 
temperatures when the spinodal temperature is approached because the amplitude of 
concentration fluctuation at higher temperature should be much larger than that of at 
lower temperature. In other words, the polymer growth rates shouldn’t be well described 
by a linear function of γc all the time when spinodal temperature is approached if LLD is 
happening in hemoglobin solution. However, on the contrary, the results on polymer 
growth rates (Alexey et al, 2011) show that all of the polymer growth rates measured at 
the temperatures and concentrations as the spinodal line is approached can be well 
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Figure 7.2. The concentration dependence of the product of polymer growth rate and 
homogeneous nucleation rate of sickle hemoglobin. The solid circles represent the 
product of polymer growth rate J and homogeneous nucleation rate f0 of sickle 
hemoglobin at 35°C measured in the work of Ferrone et al., (1985b). The solid line is the 
linear fit of those data with log10(Jf0) = −51.99(±8.31) +68.73(±11.29)×log10(c). All of 
the data are measured for samples in the demixed region.  
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Figure 7.3. The sickle hemoglobin polymer growth rate near the demixed region and 
homogenous nucleation rate in the demixed region. The filled circles show the 
temperatures and concentrations that were employed in the homogenous nucleation rate 
measurement (Ferrone et al., 1985b). The open circles show the temperatures and 
concentrations of sickle hemoglobin that were reached in the polymer growth rate 
measurement (Alexey et al., 2011). The solubility line of sickle hemoglobin (Ross et al., 
1977) is shown as the solid line and the spinodal line of deoxygenated hemoglobin (from 
Figure 5.4) is shown in the dashed line. All of the polymer growth rates measured under 
the conditions denoted by the open circles show a very good linear relation to γc. The 
homogenous nucleation rate measured under the conditions denoted by the filled circles 
still show high order concentration dependence. 
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described as a linear function of γc, and this cannot be interpreted by LLD theory.  
 
Light Scattered from oligomers 
 We interpret the increasing intensity of scattered light as due to the formation of 
oligomers. First, we tried to interpret the intensity of scattered light due to monomer and 
dimers. We obtained the equilibrium association constant of the dimer based on this 
model. Although the monomer and dimer model worked well on non-polymerizing 
hemoglobin derivatives, the equilibrium association constant of the dimer in 
deoxygenated HbS solution shows a concentration dependence which was inconsistent 
with the assumption of the monomer and dimer model. Then, we moved to the monomer 
plus one oligomer model and found that the equilibrium association constant of the 
oligomer with size 13 for the deoxygenated HbS shows the most consistent behavior. The 
13-mer being in equilibrium with monomer suggests that the oligomer with this particular 
size might be in a metastable state in the free energy landscape of the association of 
hemoglobin. The 13-mer is less stable than monomer but more stable than its neighbors. 
Or, it might reflect the size of liquid droplet as mentioned in the LLD theory although it 
seems less likely that this happens. We used the same procedure on the other hemoglobin 
derivatives and found that the particular size is 4.  
 We found the enthalpy change ΔH in the formation of oligomers is independent of 
the concentration of hemoglobin, which suggests that the mechanism for the formation of 
oligomers in hemoglobin do not change with the concentration of reactors. The enthalpy 
change ΔH per contact in oligomers in deoxygenated HbS is 0.7 kcal/mol that is quite 
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different from that of in other hemoglobin derivates, deoxygenated HbA (13.0 kcal/mol), 
deoxygenated cross-lined HbA (13.0 kcal/mol), HbACO (9.9 kcal/mol) and HbSCO (18.9 
kcal/mol) at 22.5°C, which shows that the lateral contact and the axial contact have 
different strength. The enthalpy change ΔH per contact in the formation of oligomers in 
deoxygenated HbS (0.7±0.3 kcal/mol at 22.5°C) is close to the enthalpy change for 
polymerization of deoxygenate HbS, which is 1.2 kcal/mol at 22.5°C (Ross et al., 1977; 
Weng et al., 2008). Because there are both lateral contact and axial contact in 
deoxygenated HbS and only axial contact in other hemoglobin derivatives, the ΔH due to 
lateral contact can be calculated. Since the total contacts in deoxygenated HbS 13-mer is 
36.3 and the total contact in linear tetramer is 3, we found that the ΔH due to lateral 
contact is -13.6±5.9 kcal/mol and ΔH due to axial contact is 13.7±6.1 kcal/mol by 
assuming that the number of lateral contact and the number of axial contact in the 
deoxygenated HbS 13-mer are same. The difference between ΔH due to lateral contact 
and ΔH due to axial contact might come from the 2α2His50 (Figure 1.4), which binds 
with Asp79 in the lateral contact. 
 The data of HbSCO shows surprisingly similar behavior to the data of HbA rather 
than to that of deoxygenated HbS all the time, which suggest that there are no lateral 
contacts between the HbSCO monomers since HbA monomers only have axial contacts 
between each other.  
 The free energy change per molecule due to the change of entropy in the 
formation of oligomers in deoxygenated HbS is -1.1 kcal/mol that is quite different from 
that of in other hemoglobin derivates, deoxygenated HbA (-8.3 kcal/mol), deoxygenated 
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cross-lined HbA (-8.4 kcal/mol), HbACO (-11.6 kcal/mol) and HbSCO (-6.1 kcal/mol) at 
22.5°C, which suggests that the non-polymerizing hemoglobin oligomer is more stable 
than deoxygenated HbS. The data of deoxygenated HbS always separate with that of 
other hemoglobin derivatives, which suggests that the lateral contact play a critical role in 
the formation of oligomers.  
 The entropy change per molecule in the formation of oligomers in deoxygenated 
HbS is -3.6 cal·mol-1·K-1 that is quite different from that of in other hemoglobin derivates, 
deoxygenated HbA (-28.2 cal·mol-1·K-1), deoxygenated cross-lined HbA (-28.5 cal·mol-
1·K-1), HbACO (-20.6 cal·mol-1·K-1) and HbSCO (-39.3 cal·mol-1·K-1) . The entropy 
change per molecule in the formation of oligomers in deoxygenated HbS is smaller than 
other non-polymerizing hemoglobin derivatives. It is a little bit surprised but still possible. 
Although the formation of deoxygenated HbS oligomer will bury Valβ6 in the oligomer, 
which will cause entropy loss since Valβ6 is a hydrophobic amino acid, the entropy 
change in the formation of HbA oligomers will be smaller than that of the deoxygenated 
HbS oligomer if the entropy change in the oligomers formation is only due to burying 
Valβ6, since there is no Valβ6 in the HbA molecule. However, the non-polymerizing 
oligomer has higher flexibility than deoxygenated HbS oligomer because the former one 
is linear while later one is packed, which makes the former one has much greater 
vibrational recovery than the later one (Ivanova et al., 2001). 
 When we assumed there were only monomer and another oligomer in the solution 
and found the size of the oligomer is 13 in deoxygenated HbS solution, it didn’t mean 
that there were no other oligomers in the solution. In fact, the concentration of the dimer 
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in the solution can even be a little bit higher than the concentration of the 13-mer. But the 
intensity of scattered light is still dominated by the monomer and 13-mer because the 
Rayleigh ratio is proportional to the product of concentration and the square of molar 
mass of i-mer. The equilibrium constant K13 that we obtained from this model is more 
like an “apparent” equilibrium constant rather than the exact equilibrium constant defined 
in eqn. 6.7, because the way that we used to get this equilibrium constant actually 
includes the contribution of the oligomers with other sizes in the solution.  
 We tried other subtle models assuming three or four species in the solution. 
However, those models didn’t work out well because of the lack of information about the 
relative concentrations of oligomers.  A prediction of the homogeneous nucleation 
equilibrium constant was given in the work (Ferrone et al., 1985b): 
 
ssPC
ssPCi
cRTRT
RTciRTiRTKRT
γµδ
ργµδ
ln)1(2ln23
lnlnln)4(ln
2
1
+−++
−+−+=
                            (7.4) 
here, Ki is the homogeneous nucleation equilibrium constant for i-mer, R is the gas 
constant, T is the absolute temperature of solution, δ1 = 1.29, δ2 = 0.84, µPC (= 
−7.4kcal/mol at 20°C, Cao et al., 1997) is the contribution to the chemical potential of the 
infinite polymer from the bonding free energy between molecules, ρ (=0.55) is the ratio 
of density of hemoglobin polymer to the density of monomer.  γ is the activity coefficient, 
c is the concentration monomer, cs is the solubility, and γs is the activity coefficient at 
solubility. We used the above equilibrium constant in analyzing scattered intensity data 
but the equilibrium constant drops too fast to give enough oligomer to scattered enough 
light that was observed in the light scattering experiment. The concentration of i-mer 
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predicted by the above equilibrium constant is shown in Figure 7.4. In order to fully 
understand why there is a metastable state in the aggregation, the interior structure of 
aggregates needs to be investigated in the future.  
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Figure 7.4. The concentration of i-mer in hemoglobin polymerization theory. The 
concentration Ci of i-mer as a function of oligomer size i is shown in the solid line. The 
curve is obtained by using the eqn. 7.4. (Ferrone et al., 1985b) with initial concentration 
c0 = 17.4g/dl (2.7mM) at 20°C. 
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Appendix I: Light Scattering of Multiple Components in Solution 
 
 
 In solution with multiple components, if the refractive index is expressed as a 
function of temperature T, pressure p and quantities of components ci, an infinitesimal 
variation of refractive index is given by (Stockmayer 1950; Kirkwood and Goldberg 
1950): 
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c stands for constancy of all the ci, which can be in units grams, moles, molecules.  Since 
the dependence of refractive index on pressure and temperature are sensibly only through 
the density of solution ρ,  Eq. A.1.1 can be written as 
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here, V is the scattering volume, l is the number of species in the solution, and 
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where µi is the chemical potential of ith component, and c1 is the quantity of the first 
component, which will usually be solvent. Substituting eqn. A.1.4-6 into eqn. A.1.2 and 
squaring, we obtain (Stockmayer 1950; Kirkwood and Goldberg 1950): 
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The first term of above equation comes from density fluctuation of solvent, which is 
independent of the concentration fluctuations. Since we are interested in excess scattering, 
the first term can be ignored (from eqn. 2.6).  Finally, we have: 
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Since at constant T, p and c1, we have: 
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Keep dµj but let all others dµk equal to zero, and solve for dci. ( ) µµ ,, pTjic ∂∂ can be 
described by: 
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where, |aij| denotes the determinant of all the aij, and Aij indicates the co-factor of the 
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element aij in the determinant. 
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Finally, excess Rayleigh ratio Rʹ′ can be described by(Stockmayer 1950; Kirkwood and 
Goldberg 1950): 
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here, λ is the wavelength of incident light, NA is Avogadro’s number. If weight 
concentration wi=ciMi, here Mi is the molecular weight of aggregate, ψi can also be 
described as (Stockmayer 1950; Kirkwood and Goldberg 1950): 
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If define the total aggregates concentration, ∑=
i
iwW . The chemical potential of i
th 
component µi can be denoted as (Stockmayer 1950; Kirkwood and Goldberg 1950): 
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where R is the gas constant, T is the absolute temperature, γi is the thermodynamic 
activity coefficient of ith species,
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Light Scattering in Solution of up to Four Scattering Components
 
 Based on above all of the equations, for a solution of up to four scattering 
components, indexed by i, j, k and l, we have 
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Substituting eqn. A.1.10-12, A.1.15 into eqn. A.1.16, we have: 
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Light Scattering in Solution of up to Three Scattering Components
 
 For a three species solution, eqn. A.1.18-21 reduce to the following results (from 
eqn. 2.15-19, Minton 2007). 
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where, c1, c2, c3 is the molar concentration of the first, second and third scattering specie, 
respectively.  Δc1, Δc2, Δc3, is the fluctuation of the molar concentration of the first, 
second and third scattering species, respectively. If three species are indexed by i, j, and k, 
we have: 
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and  γi, ρi, and wi denote the thermodynamic activity coefficient, the number density, and 
the w/v concentration of the ith species, respectively. 
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iiYY ρ and ∑=
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iρ1 . Hi represents an effective 
radius of the ith species of particle (Kihara, 1953), Si denotes the surface area of the ith 
species of particle, and Vi denotes the volume of ith species of particle (Minton 2007). 
The values of Hi, Si, and Vi for several particle shapes are shown in Table A.1.1.  
 If assumes that all species are represented by identically shaped particles, hi = h, si 
= s, and vi = v, it gives: 
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Substituting eqn. A.1.28-31 into eqn. A.1.27, the derivative of lnγi with respect to ρi is 
given by (Minton 2007): 
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Here, Q ≡ 1− 〈V〉. In the case of spherical particles, h = 1, s = 4π, and v = 4π/3. The value 
of radius ri of sphere can be estimated by: 
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Where veq is the specific volume of particle, for hemoglobin veq = 0.77 cm3/g. and Mi is 
the molar mass of particle. Correspondingly, the number density of the ith species ρi in the 
above eqn. A.1.27-32 will be ρi=ciNA/1000, which makes ρi in units N/cm3 if ci in units 
mol/l. 
 
Light Scattering in Solution of up to Two Scattering Components
 
 For a two species solution, eqn. A.1.22-25 reduce to the following results. 
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where, c1 and c2 is the molar concentration of the first and second scattering specie, 
respectively.  Δc1 and Δc2 is the fluctuation of the molar concentration of the first and 
second scattering species, respectively. If two species are indexed by i and j, we have: 
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And the expression of ijξ and  
j
i
c∂
∂ γln  will be same as eqn. A.1.26 and eqn. A.1.32, 
respectively. 
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Table A.1.1. Shape parameters used to calculate thermodynamic properties of hard 
particle fluids (Minton. 1981, 1998) 
 
 
 
 
 
 
Model particle H S V 
Sphere r 4πr2 4πr3/3 
Cube (r = edge) 0.75r 6r2 r3 
Right circular cylinder 
r = radius 
L = length/diameter 
(π/4+L/2)r 2π(2L+1)r2 2πLr3 
Spherocylinder 
r = radius 
L = length/diameter of 
cylindrical section 
(1+L/2)r 4π(L+1)r2 4π(1+3L/2)r3/3 
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Appendix II: The preparation of sickle hemoglobin solution by 
chromatography 
 
 
The chromatography method of preparation of sickle hemoglobin from blood was 
adopted from earlier works (Huisman and Dozy 1965; Dozy et al., 1968; Williams and 
Tsay 1973). The standard procedures in our lab were first developed by Anthony J. 
Martino and Dr. Frank Ferrrone in 1982. Recently, by repeating the procedures to prepare 
the HbS solution, we (Yihua Wang, Donna Yosmanovich and Zenghui Liu) were able to 
make some improvements. Since these procedures and improvements are not published, 
and they are essential to produce HbS solution, we decided to record them and attach this 
document to each of our theses as appendix for future reference.  
 The appendix I is arranged in the following order. Part I: a detailed list of 
equipment used in the procedure. Part II: the preparation of the concentrators. Part III: the 
preparation of the buffers. Part VI: washing of the red blood cells. Part V: lysing the 
blood cell. Part VI, Ion Exchange chromatography. Part VII, buffer exchange. 
 Let us first go over the safety requirements of this experiment. To protect the 
person who is operating with human blood sample, it is always required to wear gloves 
and goggles, and a mask is recommended. Nitrile gloves are recommended over vinyl or 
latex due to its extra durability, resistance to chemicals, tears and superior protection of 
transmittance of a human virus through the glove. All surfaces and objects that were in 
contact with human blood or blood by-products must be sprayed with a 1:10 bleach 
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solution. Wait a minimum of one minute for potential pathogens to be killed before 
wiping the surface with a disposable paper towel. 
I. Equipment used in this experiment 
All containers and equipment that will contact the hemoglobin were soaked in double 
distilled water for two hours, washed and then rinsed at least three times with twice 
distilled water. 
A. Column (approximately 21 inches long & 1 inch diameter) made out of plastic, 
with cap and attachable spigot. 
B. Three large glass jars (3 Liter or 1 gallon size) to store buffer solutions.  
C. Two 3.5L beakers for buffer preparation.  
D. Three flasks with a long neck (500 ml) for the collection of eluted hemoglobin 
from the column.  
E. Plastic dialysis tubing and the tube clamps.  
F. Dialysis bag holder, such as bendable wires.  
G. pH meter (Denver Instrument Basic model), calibrated carefully with the 
standard solutions of known pH values.  
H. Pump and Scoop with extended handle 
 
II. Preparation of the Concentrators: 
The centrifuge concentrator filters used are the Corning 20ml max volume and 6ml 
max volume with pore size 10,000 MWCO.  These are used for concentrating the eluted 
dilute hemoglobin solution.  The 20ml concentrator is used initially with solution 
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volumes of about 15ml until the hemoglobin is concentrated enough to then utilize the 
6ml concentrator.  This is done to prevent the loss of concentrated hemoglobin in the 
larger filter. Prior to use, the concentrators must be washed (washed means spinning them 
in the centrifuge) with:  
A. 70% ethanol solution 3×’s at 4500 RPM for 20 minutes 
B. With double distilled water 4×’s  at 3000 RPM for 15 minutes 
C. Then finally washed with 8.35 0.05 M Tris buffer 3×’s at 3000 RPM for 15 
minutes 
 
III. Buffer Preparation: 
It is important to have all the buffers ready before we start the experiment. For 
processing 50ml of blood the following amount of buffers are necessary:  
1) 0.9% NaCl (MW = 58.4428 g) saline solution. This solution is used to wash the blood 
3×’s (washing details are in the next section). 18 grams of NaCl powder is placed into 
double distilled H2O, and mixed extensively for 30 minutes.  The final solution 
volume is carefully adjusted to 2000ml. This saline solution can be stored in a 3L 
glass jar in a fridge. 
2) 15% NaCl (MW = 58.4428 g) solution. This solution is used to aggregate the red 
blood cell membranes after lysing the cells. 15 gram NaCl powder is placed into 
double distilled H2O, and mixed extensively before the final volume is carefully 
adjusted to 100ml.  
3) 0.05M Tris (MW =121.14g) buffer. 6.057 grams of Tris Salt powder is needed to 
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make 1L of 0.05M buffer. The pH value must be adjusted in room temperature. Three 
different pH values are needed for the Tris buffer. 1N HCL is need for the titration of 
the TRIS buffer (i.e. the HCL is an acid used to adjust the pH value). 
i. pH 8.5, final volume needed is 30L. This solution is used to wash the DE52 
cellulose, to equilibrate the cellulose column and to dialysis the Hemoglobin 
NaCl solution. 
ii. pH 8.0, final volume of 300 ml. This solution is mixed with the hemoglobin 
NaCl solution, and the mixture solution is then dialyzed in the Tris pH 8.5 buffer. 
iii. pH 8.35, final volume of 3 L. This solution is pumped into the column to 
separate the HbS band and HbA band after the Hemoglobin solution is poured 
into the column. 
4) 0.15M, pH 7.35, Sodium Phosphate buffer, final volume needed is 3 L. After the HbS 
and HbA bands separate from each other, the cellulose with the top HbA band is 
scooped out, then the phosphate buffer is poured into the column to flush out the HbS 
band quickly.  
To make pH 7.35 Phosphate buffer, we need to make the following two solutions first. 
i. Monopotassium phosphate, KH2PO4, MW=136.09 g, the solution pH is around 
4.3. 20.41 gram powder was added to 1L double distilled water. 
ii. Dipotassium phosphate, K2HPO4, MW= 174.18 g, the solution pH is around 8.5. 
52.254 gram powder was added to 2L double distilled water. 
Continuously add the mono basic solution slowly to the dibasic solution, while 
monitoring the mixture’s pH value.  Stop adding mono basic when the pH value is 
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7.35. 
5) 10-4M EDTA solution, 1L, MW =336.2 g. This solution will be used to wash the 
dialysis tubing. 0.03362 gram EDTA powder was needed to make 1L 10-4M EDTA 
solution. All buffer solutions are stored in a fridge for later use. 
 
IV. Washing human Blood: 
Sickle Blood is obtained as discarded blood from the Children’s Hospital of 
Pennsylvania (CHOP). The blood is kept on ice in a foam box during transportation from 
the hospital to the lab. 
1) 50ml blood solution is washed with about 200 ml total of 0.9% NaCl saline solution. 
The solution is mixed together with a 2ml pipette. 
2) This is centrifuged for 30 minutes at 500 RPM in a 50ml volume concentrator (not 
filled all the way). After 15 minutes, the solution separates into two parts, the liquid 
part on the top and the dense red part on the bottom. 
3)  The liquid part is removed carefully with a 2ml pipette (Eppendorf). Then more 0.9% 
NaCl solution was put into the concentrator and mixed with the cells and centrifuged 
again. 
4)  This procedure was repeated for three times, until the top part is transparent. For 
50ml blood, there was about 34 ml volume of washed blood cells. 
 
V. Lysing of the red blood cells: 
A. Breaking the membranes: 
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1) Transfer solution from above procedure into cryogenic storage vials (they can 
handle the extremely low temperature). 
2) The packed red blood cells were quickly frozen by dipping a cryogenic vial 
(4.5 ml, Fisher) into a liquid nitrogen container for 15 seconds. After being 
thawed in the fridge, the cells were flash frozen a second time. The cold shock 
is strong enough to break down the cell membranes.  
3) This procedure was repeated for a total of four dips to ensure the complete 
lysing of the red blood cell membranes. 
B. Separation of membranes and hemoglobin: The hemoglobin and membrane 
mixture solution from previous step is mixed with 15% NaCl cold solution (about 
4 degrees Celsius) to make a final NaCl concentration of 2%. This mixture 
solution is then centrifuged at 14000 RPM (Rotor JA25.50) for 1 hour.  This 
separates the cell membranes from the hemoglobin solution. After centrifugation, 
the top 2/3’s part is the precipitated hemoglobin solution, and this part is carefully 
transferred to another container with a 2ml pipette to await dialysis. 
C. Dialysis of the hemoglobin solution: Prior to dialysis the hemoglobin solution is 
mixed with 0.05M Tris, pH=8.0 buffer.  It is then placed into sterilized dialysis 
tubing and dialyzed against 0.05M tris, pH= 8.45 on a magnetic stirrer in a 
refrigerator for 36-48 hours (buffer is changed every 12 hours). Note the pH 8.45 
buffer volume is ~50 times the hemoglobin solution volume. The dialysis bags 
used hold molecules with size larger than 60,000 Daltons and diffuse out smaller 
molecules with lower molecular weights through osmotic forces. 
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VI.  Ion Exchange chromatography 
HbA, HbS and HbF were separated and purified by going through a DEAE-Cellose 
(DE52, Whatman, Inc.) column.  
The cellulose resin was mixed with 0.05M Tris, PH 8.5 buffer and stirred continually 
for 20 minutes, and then it was allowed to settle for about 30 minutes. The supernatant 
liquid was taken off and this procedure was repeated for a total of six times for a clean 
wash.  
The plastic tube column is mounted vertically to ensure the hemoglobin solution 
bands will go through without lateral deformation. After stirring the cellulose quickly to 
loosen it up (make sure it is moist enough to flow), it is poured quickly in one pour down 
the glass rod into the column.  It is important to fill it to top of the column while pouring 
because it will settle to a lower height. As shown in Figure A.2.1. 
The cellulose is kept under a flow of 0.05M pH 8.5 Tris buffer till the output is pH 
8.5 as well, and then the column is considered equilibrated. This takes about 12 hours. 
 Figure A.2.1 Column poured with cellulose: Notice the plastic tubing 
connected to an pump; the buffer container covered in parafilm on the 
left (which is the clean buffer reservoir); and the container under the 
spigot of the column used to collect buffer flowing out. 
After equilibration, the hemoglobin solution is slowly and 
carefully put into the column with a 50ml syringe without disturbing the top surface of 
the cellulose. Upon completion of adding the hemoglobin, the next step waits for when 
176 
 
the Hb has mostly entered the top of the cellulose (but before the cellulose can be in any 
danger of drying), pH 8.35 buffer is then pumped into the column. We continue to pump 
in this buffer for the rest of the procedure to enable the separation of different 
hemoglobin species. This is shown in the Figure A.2.2. 
 
 
 
Figure A.2.2  Hb solution starting to enter the cellulose. 
  
 After ~8 hours, the hemoglobin solutions start to separate into three bands, HbF, 
HbS and HbA (from the bottom to the top). To get the HbS band out quickly, after the 
HbF has eluted from the column, we scoop out the top band (HbA) and dispose of this.  
Then the HbS band can be eluted out quickly using the 0.15M phosphate buffer.  
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Figure A.2.3: The separation of hemoglobins. HbF is dark bottom band, HbS is second, 
HbA and HbA2 sits in the top portion. 
 
 
The HbS Tris solution is centrifuged (5500g, 1 hour) to ~4g/dl with previously 
washed concentrator filters. The HbS Tris solution is stored in liquid nitrogen for future 
usage in a PD-10 ion exchanger. 
VII.  The Hemoglobin buffer exchanging procedures 
To exchange the hemoglobin solution from Tris buffer to Phosphate buffer, we will 
have the hemoglobin solution go through a column (Amersham PD-10, 9ml column of 
Sephadex G-25). The elution collected was hemoglobin molecules in the Phosphate 
buffer. A masterflex pump system including the tube, the pump head (i.e. the cartridge) 
and the pump controller (Model No. 7553-60) was setup to deliver the Phosphate buffer 
to the top of the column with precise flow speed control. Here are the detailed procedures. 
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1) Washing the pump tube with water. 250 ml double distilled water was pumped 
through to wash the inside of the tube. 
2) Washing the pump tube with Phosphate buffer. Another 100 ml Phosphate buffer 
was pumped through to rinse the inside rubber tube. 
3) Setting up the PD-10 column. PD-10 column was mounted on the bench 
vertically. After the cap of the column was taken off, and the bottom of the 
column was cut open, Phosphate buffer was pumped into the column. The flow 
speed was set around 3.5/10 position, so that the water level was kept 1 cm on 
top of the column surface.  
4) After about 25ml Phosphate buffer was flushed through the column, the pump 
controller was turned off. At the moment the water level drop to the top surface 
of the column, around 300ul Tris HbS solution was delivered onto the column. 
When the hemoglobin solution completely enters the gel, the pump controller 
was turn on with full speed (10/10). Once there were around 2.5 ml buffer 
accumulated at the top of the column, the pump controller was adjusted back to 
3.5/10 position. 
5) When the hemoglobin solution elute out of the column, collect it with previously 
washed centrifuge filters (The procedures to wash the filters are described in step 
II). 
6) After another 25 ml Phosphate buffer was pumped through the column, we repeat 
step 4)  and 5) until all hemoglobin are processed. 
6) Repeat procedure 2), and then procedure 1), so as to leave no salt in the pump 
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tube. 
7) We centrifuged (Beckman coulter, Avanti J-25) the hemoglobin solution to the 
desired concentration, and then store it in liquid nitrogen for future experiment 
usage. 
It is about 12 hours work to exchange 2 ml Hemoglobin solution from Tris buffer to 
Phosphate buffer. 
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Appendix III: Dynamic light scattering in polydisperse solutions 
 
 
 
 
 In many books, the intensity correlation function is also noted as g2(q, τ): 
 ),(),(),(2 ττ += tqItqIqg                                                  (A.3.1) 
here q is the scattering vector, I is intensity of scattered light, t represents time, and τ is a 
certain time interval. Correspondingly, the dynamic structure factor is called g1(q, τ).   
)),(1(),( 212 ττ qgBAqg +=                                                (A.3.2)  
where, A is the measured baseline:  
2),( tqIA =                                                           (A.3.3) 
and B is a parameter depending on the coherence of the detection. Ideally, B=1.  
 One of most common methods of analyzing dynamic light scattering data in 
polydisperse solutions is the cumulant method (Koppel 1972). In this method, ln(g1(q, τ)) 
is expanded as, 
      
……332211 !3!2
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                                            (A.3.4) 
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where, Γavg is average decay rate, Dz is called z-average diffusion coefficient, which will 
correspondingly yield an average hydrodynamic radius 〈RH〉.  
      ∑
∑≡ 2
2
ii
iii
z MN
DMN
D
                                                            (A.3.8) 
and 〈(δD)2〉z is the variance in Dz.  
( ) 222
zzz
DDD −=δ
                                                   (A.3.9) 
k2 gives the variance of the distribution, and k3 is measure of asymmetry of the 
distribution. For a Gaussian distribution, only k1 and k2 are non zero. Using parameters 
beyond k3 is highly not recommended because fitting data with too many parameters in a 
power-series expansion will make k1, k2 less precise. 
 In order to get above results, several assumptions have been made. 1) There are 
no interactions between scattering particles in solution (sufficiently diluted). 2) There is 
no interference in one molecule (small scatters or small q). The cumulant method gives 
just cumulants (moments) rather than actual distribution function. The cumulant method 
is valid for small τ with reasonably narrow distribution ΔRH/〈RH〉≤20% (Schärtl 2007). In 
the case of large asymmetry in the size distribution, the method fails.  
 Another method for analyzing the correlation function is CONTIN algorithm, 
which estimates the distribution function G(Di) of selfdiffusion coefficient Di directly 
using regularized Laplace inversion of the correlation function (Provencher 1979, 1982a, 
b). The CONTIN can be used to solve polydisperse systems with broad distribution or 
bimodal systems which are difficult to cumulant method.  The method needs enough 
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large number of experimental data to numerically fulfill Laplace inversion precisely. 
Although CONTIN was created to solve G(Di) without without any other information but 
g1(q, τ), any priori knowledge constraining the distribution can improve the accuracy of 
the result. In some case, distribution function can only be obtained if number weighted 
radius distribution function is known (Maulucci 2005).   
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